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ABSTRACT
Moisture-damage is common in buildings, and it is associated with a variety of adverse health
effects, especially inflammatory responses in the lower airways. Exposure to microbial spores
or cells has been suspected to be one reason for the inflammation, but the inflammatory and
toxic potential of the microbes has not been well characterized.
In this study, a mouse model was devised to elucidate and compare the adverse effects
provoked by microbes isolated from the indoor air of a moisture-damaged building. The
animals were exposed intratracheally to the microbial spores or cells. The effects caused by
the bacterial species Streptomyces californicus and Mycobacterium terrae and the fungi
Aspergillus versicolor and Penicillium spinulosum were investigated. They are typical
microbes observed in moisture-damaged buildings, but P. spinulosum is also frequently
observed in all indoor air environments. Both the dose-response and time-course of the
inflammatory and toxic responses were investigated after a single dose of the microbe.
Biochemical parameters indicating inflammation and/or toxicity (tumor necrosis factor α,
TNFα, interleukin-6, IL-6, total protein, albumin, hemoglobin and lactate dehydrogenase)
were measured from bronchoalveolar lavage fluid (BALF), and a histopathological analysis
was performed from lungs, lymph nodes and spleen. In addition, inducible nitric oxide
synthase (iNOS) was determined from lavaged cells, and the cytokine concentrations were
measured in serum. Moreover, the effects of S. californicus were studied after repeated dosing
of the spores. In that experiment also lymphocyte subpopulations were investigated in the
lungs, lymph nodes and the spleen.
Both the biochemical parameters and histopathology revealed that all the microbes studied
provoked inflammation after a single dose, but the magnitude and its characteristic features
were different. The spores of S. californicus provoked a very intense acute inflammation
indicated by a strong and rapid IL-6 and TNFα production in the lungs, recruitment of
inflammatory cells into the airways, and expression of inducible nitric oxide synthase (iNOS)
in lavaged cells at 24 hours. An increase in TNFα and IL-6 concentrations in serum was also
detected. The cells of M. terrae induced a biphasic inflammatory response, which consisted of
an acute and a sustained phase. In the acute phase, TNFα and IL-6 were produced and
inflammatory cells were recruited into the lungs. In the later phase, TNFα production was
sustained up to 14 days, and inflammatory cell recruitment was even more intense, with iNOS
being expressed in lavaged cells. Reactive changes in lymph nodes were also observed. The
inflammatory response lasted until the end of the experiment (28 days), and at that time some
mycobacterial cells were still present in the lungs.
At comparable volumetric doses with the bacteria, the fungal species also induced a rapid
production of proinflammatory cytokines, and inflammatory cell recruitment into the airways,
but they were generally less potent than the bacteria. P. spinulosum induced only a mild
inflammatory response and transient TNFα and IL-6 production into BALF. The spores of
A. versicolor caused a slow TNFα response, and the inflammatory cell response was more
sustained than by P. spinulosum. In contrast to the bacteria, the studied fungal species did not
induce expression of iNOS. 
Acute cytotoxicity in lungs indicated by LDH response was observed during S. californicus,
M. terrae and A. versicolor exposure. M. terrae exposure caused the strongest and most
sustained effect. However, none of the microbes were highly cytotoxic in the lungs, and the
effect was frequently associated with an acute inflammatory response. P. spinulosum
exposure showed no cytotoxic effect.
After repeated airway exposure to the spores of S. californicus, both the innate and adaptive
host defenses were activated in the lungs. The inflammatory cell response in the lungs was
more severe and appeared at a lower dose level than after a single dose. Spleen cell count was
decreased indicating a systemic immunotoxic effect, and the lymphocyte subpopulations were
altered in the lungs, lymph nodes and the spleen. Reactive changes were observed in lymph
node histopathology.
In summary, the results show that the indicated microbes have a different potential to cause
inflammatory and toxic responses after airway exposure in mice, and suggest that microbes
present in a moisture-damaged building can induce inflammation in lungs and cause systemic
toxicity. 
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ABBREVIATIONS
A. versicolor    Aspergillus versicolor
ALL    alveolar lining layer
AP    alkaline phosphatase
aw    water activity
BAL    bronchoalveolar lavage
BALF    bronchoalveolar lavage fluid
BCIP    bromo chloro indolyl phosphate disodium
BSA    bovine serum albumin
cAMP    cyclic adenosine monophosphate
CD    clusters of differentiation
cGMP    cyclic guanosine monophosphate
CO2    carbon dioxide
DNA    deoxyribonucleic acid
EDTA    ethylene diaminetetra-acetic acid
ELISA    enzyme linked immuno sorbent assay
FBS    fetal bovine serum
FACS    fluorescence activated cell sorter
FITC    fluorescein isothiocyanate
g    acceleration of gravity
HBSS    Hank's balanced salt solution
HRP    horse radish peroxidase
IFN    interferon
Ig    immunoglobulin
IL    interleukin
iNOS    inducible nitric oxide synthase
kDa    kiloDalton
LAM    lipoarabinomannan
LDH    lactate dehydrogenase
LPS    lipopolysaccharide
M. terrae    Mycobacterium terrae
MHC    major histocompatibility complex
MVOC    microbial volatile organic compound
NBT    nitro blue tetrazolium
NK cell    natural killer cell
NO    nitric oxide
NO2-    nitrite
NO3-    nitrate
NOS    nitric oxide synthase
OONO-    peroxynitrite 
P. spinulosum    Penicillium spinulosum
PAF    platelet activating factor
PBS    phosphate buffered saline
PDE    phosphodiesterase
PE    phycoerythrin
PerCP    peridinin chlorophyll protein
PMSF    phenyl methyl sulfonyl fluoride
RAW264.7    mouse macrophage cell line
ROS    reactive oxygen species
rpm    revolutions per minute 
S. californicus    Streptomyces californicus
SCG    single cell gel
SE    standard error
SDS    sodium dodecyl sulfate
SPF    specific pathogen free
spp.    species
TCR    T cell receptor
Th cell    helper T cell (CD3+CD4+)
Tk cell    killer T cell (CD3+CD8+)
TMB    tetramethylbenzidine
TNFα    tumor necrosis factor alpha
TXA2    thromboxane A2
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1 INTRODUCTION
Moisture-damage in buildings is common in different climates (e.g. Hunter et al., 1988; Dales
et al., 1991a; Nevalainen et al., 1998). In Finland, signs of current or previous moisture-
damage have been reported in up to 80% of houses (Nevalainen et al., 1998). Several
epidemiological studies have indicated that there is an association between the adverse health
effects experienced by the occupants and the presence of moisture-damage in buildings. In
particular symptoms and diseases in the upper or lower airways have been observed, but a
number of general symptoms have also been reported. 
Excess moisture encourages microbial growth on building materials. Increased numbers of
microbes or their spores, and atypical microbial species have been frequently detected in the
indoor air of moisture-damaged buildings (e.g. Waegemaekers et al., 1989; Nevalainen et al.,
1991; Hyvärinen et al., 1993; Samson et al., 1994). It is possible that the microbes have a role
in inducing the adverse health effects observed among the occupants of such buildings.
However, there is little toxicological data concerning these microbes. In particular, more in
vivo data in experimental conditions during airway exposure are needed. The data from
animal studies permit the analysis of whole lung and organism responses to the microbial
exposures. In addition, the function of the complex immune system, composed of a network
of diverse cell types, can be more thoroughly investigated. In this thesis in vivo effects
induced by four microbes isolated from moisture-damaged buildings were evaluated to obtain
new information for the health risk assessment.
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2 REVIEW OF LITERATURE
2.1 Exposure in moisture-damaged buildings
The occupants of moisture-damaged buildings are exposed to different substances of
microbial or other origin. Several microbes (e.g. fungi and actinobacteria) produce spores that
can spread into indoor air. The occupants can also be exposed to microbial cells, hyphae or
their fragments, since particles other than spores can be released from fungal cultures
(Kildesø et al., 2000; Gorny et al., 2002). Microbes can produce toxic secondary metabolites
(e.g. mycotoxins) and they possess bioactive surface structures (e.g. bacterial endotoxins)
(Young et al., 1998; Peraica et al., 1999). Fungi and actinobacteria (previously known as
actinomycetes) can also emit volatile organic compounds (MVOC's) (Pieckova and Jesenska,
1999; Scholler et al., 2002). In addition to microbial exposure, increased moisture and
microbes may decompose building structures, and cause volatile emissions from the materials
(Pasanen et al., 1998; Wolkoff and Nielsen, 2001). Exposure to mite allergens may also
explain some of the adverse effects (Bornehag et al., 2001). Altogether, the relative
importance of different indoor air exposures in provoking adverse health effects is not known.
It has been especially difficult to obtain quantitative relationships between exposure and the
symptoms. Moreover, several other factors, such as insufficient ventilation, high temperature
and draft can influence the perception of indoor air quality and modify the effects caused by
biological and chemical contaminants in indoor air of moisture-damaged buildings (Husman,
1996).
Dampness and visible mold growth in the buildings are frequently associated with increased
levels of fungal spores in indoor air (Hunter et al., 1988; Hyvärinen et al., 1993; Li and
Kendrick, 1995; Garrett et al., 1998; Dharmage et al., 1999; Hyvärinen et al., 2001a).
Especially, during repair of moisture-damage, the number of microbes is markedly increased
in indoor air (Rautiala et al., 1996). Both fungi (e.g. Stachybotrys, Penicillium and
Aspergillus) and bacteria (e.g. actinobacteria (e.g. Streptomyces), mycobacteria and
Pseudomonas) have been isolated from the indoor air and building materials of moisture-
damaged buildings (Hunter et al., 1988; Nevalainen et al., 1991; Hyvärinen et al., 1993;
Samson et al., 1994; Andersson et al., 1997; Hyvärinen et al., 2002; Rautiala et al.,
submitted). Even though the measured microbial concentrations are not necessarily high in
the indoor air, the atypical, potentially toxigenic, microbial species may cause adverse health
17
effects even at lower concentrations (Husman, 1996). The microbial species, which are
regarded as moisture-indicator microbes in the literature are listed in Table 1. Their
appearance is partly dependent on the water activity (aw) of a building material. 
Table 1. Microbes regarded as moisture-indicator organisms (Modified from Samson et
al., 1994).
• Materials with a high water activity (aw > 0.90 - 0.95)
Aspergillus fumigatus
Actinobacteria
Exophiala
Fusarium
Gram-negative bacteria (e.g. Pseudomonas)
Phialophora
Stachybotrys
Trichoderma
Ulocladium
yeasts (Rhodotorula)
• Materials with a moderate water activity (0.85 < aw  < 0.90)
Aspergillus versicolor
• Materials with a lower water activity (aw ≤ 0.85)
Aspergillus versicolor
Eurotium
Penicillia (e.g. Penicillium chrysogenum, P. aurantiogriseum)
Wallemia
Several species of these microbes can produce toxic compounds. One of the most thoroughly
investigated toxigenic fungus in indoor air is Stachybotrys chartarum, which can produce a
diverse spectrum of toxins (Jarvis et al., 1995; Fung et al., 1998). Aspergillus versicolor and
Fusarium species are other examples of toxin producing fungi (Samson et al., 1994).
Moreover, Gram-positive bacteria streptomycetes have the capability to produce several
different agents, including toxic substances (Arcamone, 1998; Paananen et al., 2000; Bolzan
and Bianchi, 2001; Watve et al., 2001).
2.2 Adverse health effects associated with moisture-damage in buildings
The association between adverse health effects and exposure in moisture-damaged buildings
has been shown in several epidemiological studies (Table 2). The epidemiological evidence is
strongest for respiratory adverse effects (cough, wheeze and asthma) (Bornehag et al., 2001).
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Moreover, a number of general symptoms have been reported. However, all adverse effects
have apparently not been identified yet. 
Table 2. Symptoms and diseases associated with moisture-damages in buildings.
• Respiratory tract symptoms and diseases
- cough (Brunekreef, 1992; Koskinen et al., 1999a, 1999b)
- wheeze (Platt et al., 1989)
- asthma (Waegemaekers et al., 1989)
- phlegm (Brunekreef, 1992; Pirhonen et al., 1996) 
- dyspnoea (Platt et al., 1989)
- bronchitis (Dales et al., 1991b)
- increased respiratory infections (Koskinen et al., 1995, 1997)
- pulmonary hemosiderosis (Etzel et al., 1998; Dearborn et al., 1999)
- hypersensitivity pneumonitis (Park et al., 1994; Lee et al., 2000)
- hoarseness (Koskinen et al., 1995, 1999a; Pirhonen et al., 1996)
- sore throat (Platt et al., 1989)
- nasal congestion (Platt et al,. 1989)
- nasal discharge (Platt et al,. 1989)
- rhinitis (Pirhonen et al., 1996)
• Other symptoms and diseases
- skin symptoms (Johanning et al., 1996)
- eye irritation (Hodgson et al., 1998; Johanning et al., 1996)
- difficulties in concentrating (Koskinen et al., 1999b)
- fatigue (Koskinen et al., 1999b, Johanning et al., 1996)
- lethargy (Hodgson et al., 1998)
- nausea (Koskinen et al., 1999b)
- lumbar backache (Pirhonen et al., 1996)
- recurrent stomachache (Pirhonen et al., 1996)
- aching joints (Platt et al., 1989)
- rheumatic diseases (Roponen et al., 2001)
2.3 Potential mechanisms and other effects
The mechanisms behind most of the observed adverse health effects associated with exposure
in moisture-damaged buildings remain unknown, with both immunological and non-
immunological mechanisms being suspected (Damgård Nielsen et al., 1995). 
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Immunostimulation and allergy
Exposure to microbes and their toxic substances may trigger innate immune responses i.e.
increased production of inflammatory mediators, such as cytokines, and reactive oxygen and
nitrogen radicals in mammalian cells in vitro (Ruotsalainen et al., 1995; Hirvonen et al.,
1997a, 1997b, 1997c; Huttunen et al., in press). These responses are important elements in the
normal host defense, but sustained or excess release of inflammatory mediators and toxic
radicals may provoke adverse health effects. For example, increased phagocytic clearance by
inflammatory cells recruited to the site of exposure is an important component of host
defense, but inflammatory cells can provoke immunopathological effects also to the host via
their products (Stockley, 1995). 
One of the best known immunological mechanism for an adverse health effect caused by
fungal exposure is immunoglobulin E (IgE) -mediated immediate allergy (Gell and Coombs
classification Type I). The most prevalent indoor air fungal species causing IgE-mediated
allergy include Aspergillus, Cladosporium, and Penicillium (Ledford, 1994), though many
other fungi have also been associated with allergy (Kurup et al., 2000). This mechanism has
been linked to the occurrence of rhinitis and asthma (Samson et al., 1994). The prevalence
estimates of IgE-mediated mold allergy vary considerably (5% - 50%) in different populations
(Husman, 1996). In the general population, the prevalence of fungal allergy has been
estimated to be 6%, whereas among atopic individuals it can be as high as 20% to 30%
(Kurup et al., 2000). IgE-mediated allergy can explain only part of the observed symptoms
and diseases. Taskinen and co-workers (1997, 1999, 2001) have shown that fungal allergy, as
assessed by IgE measurements or skin tests was rare, although the symptoms and diseases
were increased in moisture-damaged environments. Some fungi, especially Stachybotrys
chartarum can trigger histamine release from human leukocytes by non-IgE-mediated
mechanisms (Larsen et al., 1996). Thus, the fungal exposure may cause histamine-mediated
symptoms also in non-sensitized population.
Another immunological reaction caused by microbial exposure is the immune complex-
mediated (Type III) mechanism. This has been associated with extrinsic allergic alveolitis (i.e.
hypersensitivity pneumonitis) and humidifier fever (Samson et al., 1994; Husman, 1996). The
cell-mediated (Type IV) mechanism has also been reported to be provoked by fungal
exposure (Samson et al., 1994; Tomee and van der Werf, 2001). The diagnosed cases of these
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two latter types of allergies have been reported only occasionally to be connected with
exposure in moisture-damaged buildings, but possibly this is partly due to underdiagnosis
(Husman, 1996).
Immunosuppression and infections
In addition to immunostimulation or hyperreactivity, exposure to indoor air microbes or their
products has been suspected to cause immunosuppression. The increased frequency of
infections among occupants in moisture-damaged buildings suggests that host defense
mechanisms have been impaired. Possible mechanisms include toxic effects on ciliated cells
in the airways and subsequently impaired particle clearance (Pieckova and Jesenska, 1996,
1998), and toxic effects on other cells of the immune system (e.g. lymphocytes and alveolar
macrophages). Several microbial products, such as trichothecene mycotoxins and products of
actinobacteria have immunosuppressive potential (Pestka and Bondy, 1990; Ochiai et al.,
1993; Wallemacq and Reding, 1993; Sorenson, 1999). The increased microbial burden and
abnormal microbial composition in the buildings (e.g. opportunistic pathogens) may cause
infections in individuals with an impaired host defense or poor health. Individuals at increased
risk include immunocompromised patients, and patients suffering from respiratory diseases
like chronic obstructive pulmonary disease. For example, Aspergillus species, especially
A. fumigatus may cause pulmonary aspergillosis with different degrees of severity (Tomee
and van der Werf, 2001). The most harmless manifestation of pulmonary aspergillosis, is
"non-pathogenic saprophytic colonization" which is common even in healthy individuals.
This type of microbial colonization should not cause tissue damage, and the healthy host will
recover without treatment. In aspergilloma, the mycetoma (fungus ball) grows as a saprophyte
in a preformed and poorly drained lung space. Hypersensitivity-induced aspergillosis includes
Aspergillus asthma, allergic bronchopulmonary aspergillosis, and extrinsic allergic alveolitis.
The most severe manifestation of aspergillosis is invasive aspergillosis, which is a generalized
fungal infection.
Autoimmunity
Exposure to microbes in moisture-damaged buildings may also cause autoimmune reactions
and diseases. An increased incidence of rheumatic diseases and aching joints have been
reported in the occupants of moisture-damaged buildings (e.g. Platt et al., 1989; Roponen et
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al., 2001). Microbes can induce autoimmunity, i.e. a direct immune response against host.
Activation and subsequent clonal expansion of autoreactive lymphocytes (the cells that
recognize and react against self-molecules) is a critical step in the pathogenesis of
autoimmune disease (Wucherpfennig, 2001). Microbes can activate autoreactive T and B
lymphocytes via several mechanisms (Table 3).
Table 3. Mechanisms which may lead to autoimmunity after microbial exposure (modified from
Wucherpfennig, 2001).
• Mechanisms based on microbial products or structures
- Molecular mimicry. Sufficient homology between microbial immunogenic peptides and self-
peptides that leads to activation of autoreactive lymphocytes. 
- Microbial superantigens. Microbial molecules that induce uncontrolled stimulation and an
inappropriate T cell response. Subpopulation of these cells may be autoreactive.
• Inflammation associated mechanisms 
- Enhanced processing and presentation of autoantigens. During inflammatory process antigen
processing and presentation are enhanced by antigen presenting cells recruited to the site of
inflammation leading to activation of autoreactive lymphocytes.
- Bystander activation. Inflammation may increase the proliferation of previously activated
autoreactive lymphocytes. 
One possibility is that the cells do not recognize self-molecules, but instead persistent
microbes or microbial antigens (structures/molecules) that have been carried along migrating
phagocytes to the synovial tissues in the joints during long-term exposure. This has been
suggested to be another mechanism, in addition to recognition of self molecules, contributing
to the development of reactive arthritis (Wucherpfennig, 2001). DNA and RNA of
Chlamydia, which is an intracellular bacterium, have been frequently detected from the
synovial membrane or fluid during reactive arthritis. Very little is known about the possible
role of microbial contaminants and mechanisms of autoimmune reactions in moisture-
damaged environments.
Cytotoxicity
Microbial toxins can cause cytotoxicity which may be mediated via either apoptotic or
necrotic mechanisms (Paananen et al., 2000; Yang et al., 2000; Etzel, 2002). However, other
effects may occur at lower exposure levels not sufficient to induce cell death. For example,
the mitochondrial toxin valinomycin produced by Streptomyces griseus reduced the natural
killer (NK) cell-mediated cytotoxicity and cytokine production at a lower concentration than
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that causing apoptotic cell death (Andersson et al., 1998; Paananen et al., 2000). Cytotoxic
effects may also be directed against other cells, including leukocytes (e.g. alveolar
macrophages, lymphocytes) and epithelial cells, and disturb both innate and adaptive host cell
responses.
Neurotoxicity
The symptoms like fatigue and difficulties in concentrating (e.g. Koskinen et al., 1999b,
Johanning et al., 1996) point to effects on the central nervous system. The products of
Fusarium (fumonisin B1, deoxynivalenol), Aspergillus (ochratoxin A) and Penicillium
(ochratoxin A, verrucosidin) species have been shown to possess neurotoxic potential (Rotter
et al., 1996; Belmadani et al., 1999; Kwon et al., 2000; Nunez et al., 2000). Also compounds
that enhance neurite (axon and dendrite) outgrowth from neuronal cells have been isolated
from fungal cultures (Nozawa et al., 1997).
Irritation
Microbial products such as microbial volatile organic compounds (MVOC's) may cause
irritation via neurogenic mechanisms. When chemosensitive receptors are activated in the
airways and alveoli, the subsequent local release of neuropeptides (e.g. substance P and
neurokinin A) may provoke neurogenic inflammation (Damgård Nielsen et al., 1995). Some
of the neuropeptides can also affect innate immune responses. Substance P increases
phagocytosis and enhances neutrophil accumulation and reactivity by facilitating the actions
of other inflammatory mediators (Mathison et al., 1993; Damgård Nielsen et al., 1995).
Genotoxicity
Some microbial toxins are genotoxic and carcinogenic. Inhalation exposure to a mycotoxin
produced by Aspergillus flavus, aflatoxin, has been associated with lung or colon cancer
(Olsen et al., 1988; Sorenson, 1999). Naturally occurring aflatoxins are human carcinogens,
and several other toxins and secondary metabolites including adriamycin, daunomycin (i.e.
daunorubicin) and streptozotocin (produced by streptomycetes), sterigmatocystin and
ochratoxin A (Aspergillus and Penicillium), and fumonisins B1-2, and fusarin C (Fusarium)
have been considered risk factor for cancer (IARC, 1987; 1993). However, no
23
epidemiological or experimental data have been published concerning exposure in moisture-
damaged buildings and risk of cancer.
Reproductive toxicity
Adverse effects during pregnancy are also possible. An association between occupational
exposure to mycotoxins and late-term abortions has been proposed (Kristensen et al., 1997),
and mycotoxins have been reported to cause reproductive toxicity in animals (Korpinen,
1974). Oral exposure to Stachybotrys chartarum during the early phase of pregnancy
provoked reproductive toxicity in mice (Korpinen, 1974). Very little is currently known about
these forms of toxicity in moisture-damaged indoor environments. 
2.4 Host defense with special reference in lungs 
2.4.1 Physiological defenses in lungs
The lungs possess a variety of structural, mechanical, chemical and cellular strategies to
guarantee proper function and form of the airways for effective gas exchange (Whitsett,
2002). A major part of larger particles (> 5 µm) is removed by filtration from the inhaled air
in the upper airways (Zhang et al., 2000). Most of the microbes or spores in the indoor air of
moisture-damaged buildings are at the size-range which allow them to deposit also to the
alveolar level (Hyvärinen et al., 2001b). Even the relatively large spores of Stachybotrys
chartarum (aerodynamic diameter approximately 4 - 5 µm) can penetrate the alveoli
(Sorenson, 1987). The physiological defense mechanisms in the lungs include the coughing
reflex and the ability to evoke bronchoconstriction (Sant'Ambrogio and Widdicombe, 2001).
Several cell types are important for proper host defense responses in the lungs. The epithelial
cell types include ciliated, non-ciliated bronchiolar (Clara cells), mucus producing (goblet
cells), neuroepithelial cells, and type II and type I alveolar epithelial cells (Whitsett, 2002). In
addition, phagocytic cells are normally found in the lungs.
2.4.2 Innate host defense
When microbial contaminants enter the lungs, they will first encounter the innate host
defense. Epithelial cells are an effective physical barrier which can also produce mucus, and
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transport the adhered contaminants to the pharynx via cilia movement (Zhang et al., 2000;
Knowles and Boucher, 2002). The transported mucus and contaminants are either swallowed
into the gastrointestinal tract or expectorated. In addition to the mechanical clearance,
respiratory secretions in the airways have antimicrobial effects (Ganz, 2002). These secretions
are produced by several cell types, including epithelial cells, especially goblet cells,
submucosal glands, and resident as well as recruited phagocytes. Moreover, transudation and
transport of proteins from circulation into the airways can occur. Important secretory cells in
the distal airways include alveolar epithelial cells, such as Clara cells and type II epithelial
cells. The broad antimicrobial effects of respiratory secretions are mainly attributable to
cationic polypeptide components, such as the cell-membrane degrading enzyme lysozyme, the
iron-chelating protein lactoferrin, secretory leucoprotease inhibitor, neutrophil and epithelial
defensins which permeabilize cell-membranes, and cathelicidins which have a diverse range
of antimicrobial activity (Ganz, 2002; Ramanathan et al., 2002). 
Agents that reach the alveolar level and which become deposited into the alveoli come into
contact with the alveolar lining layer (ALL) (McCormack and Whitsett, 2002). ALL is a thin
aqueous film containing pulmonary surfactant. Its components, including pulmonary
collectins, also participate in the innate host defense (LeVine and Whitsett, 2001; McCormack
and Whitsett, 2002). The primary components of antimicrobial defense in alveolar region for
naive host are resident alveolar macrophages and the protein components present also in
respiratory secretions. Alveolar macrophages are phagocytic cells that decontaminate the
alveolar walls. They are activated by innate immune receptors such as CD14 and Toll-like
receptors (TLRs), which detect lipopolysaccharide (LPS) molecule on the surface of Gram-
negative bacteria. Phagocytosis is triggered by several different kinds of receptors (e.g.
mannose receptor, macrophage scavenger receptor) (Greenberg and Grinstein, 2002).
Endocytic pattern-recognition receptors are located on the surface of the phagocytes, and they
can identify microbial structures and promote phagocytosis (Medzhitov and Janeway, 2000).
If a microbe has been encountered previously, the phagocytosis can also be triggered by Fc-
receptors after the microbe has been opsonized by specific antibodies. Phagocytized microbes
are destroyed in phagolysosomes by the action of lethal radicals and hydrolytic enzymes
(Greenberg and Grinstein, 2002). Innate pattern-recognition receptors have been functionally
divided into two more classes in addition to endocytic receptors: secreted and signaling
receptors (Medzhitov and Janeway, 2000). Secreted pattern-recognition receptors, such as
mannan-binding lectin are opsonins that bind to the microbial structures and flag the
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microorganism to the phagocytes and the complement system for recognition. Signaling
pattern-recognition receptors activate signal-transduction pathways after recognition of
microbial structures leading to the induction of inflammatory cytokine production. The Toll-
like receptor family is an example of signaling pattern-recognition receptors. Inflammatory
mediators, such as cytokines produced by activated alveolar macrophages, may provoke early
induced non-adaptive inflammatory responses, e.g. recruit neutrophils into the airways or
induce production of acute-phase proteins in the liver (Janeway and Trawers, 1997).
The complement system, a cascade of serum proteins, can attack invading microorganisms.
The complement system activated by antibody-independent alternative (initiation by C3b
protein) or lectin-mediated pathway is one of the innate host defense mechanisms in the lungs
(Medzhitov and Janeway, 2000). Moreover, during the activation of the complement cascade,
inflammatory mediators, such as C5a, C4a, and C3a, are released (Delves and Roitt, 2000a).
These mediators can recruit and activate neutrophils, and also trigger the release of histamine
from mast cells. 
Since the innate immunity responds more rapidly than the adaptive immunity, it is crucial also
for the antimicrobial immunity in the lungs (Medzhitov and Janeway, 2000). Even though the
diversity of the recognition patterns in the innate receptors is nowhere near the repertoire of
antigen specific receptors in the adaptive host defense, innate receptors still effectively
recognize common and conserved structural patterns in microbes. Moreover, properly
functioning innate responses are also important in initiating and directing the responses of the
adaptive host defense. Innate host defense responses do not adapt during the exposure. The
response neither intensifies during the later exposure nor does it possess memory.
2.4.3 Adaptive host defense
Lymphocytes, fundamentally divided into T and B cells, are crucial cells for the adaptive
immunity (Delves and Roitt, 2000a). In addition, there is increasing evidence of
unconventional lymphocytes that do not clearly belong to traditional T or B cell types (Tabata
et al., 1996; Penttilä et al., 1998; Phyu et al., 1999; Zuckermann, 1999). However, their
functions are not well understood.
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T cells include CD4+ and CD8+ subpopulations (Delves and Roitt, 2000b). CD4+ T cells are
mainly cytokine-secreting helper cells, whereas CD8+ cells function as cytotoxic killer cells
(Tk cells). Helper T cells have been further divided into two major subpopulations, Th1 and
Th2, based on their cytokine profiles (Mosmann and Sad, 1996). Type 1 helper cells
preferentially produce interferon-γ (IFNγ) and IL-2 but not IL-4, IL-5 or IL-6. Type 2 T cells
produce, for example, IL-4, IL-5, IL-6 and IL-10 but not IFNγ or IL-2 (Delves and Roitt,
2000b; Moore et al., 2001). A simplified view is that Th1 cytokines enhance cell-mediated
immunity for example by activating macrophages or T cell-mediated cytotoxicity, and Th2
cytokines stimulate B cells to produce antibodies. 
Cytotoxic T cells can kill cells that introduce foreign peptides from their cytoplasm via major
histocompatibility complex (MHC) class I -molecules (Delves and Roitt, 2000b). These
peptides are a sign of an intracellular infection for Tk cells. Killing can be executed by two
mechanisms: A) Tk cells can secrete perforins which produce pores in the cell membrane of
the target cell, and then proteolytic enzymes, granzymes enter into the target cell from the Tk
cell. Granzymes induce apoptotic cell death. B) Tk cells can also induce apoptosis via a Fas-
mediated pathway. CD8+ cells presumably include other subpopulations than traditional Tk
cells, as well as Th cells (Moore et al., 2001).
Plasma cells, differentiated from B cells after antigen recognition and the cell activation, are
responsible for antibody production (Delves and Roitt, 2000b). Antibodies can be self-
protective if they inhibit direct contact between microbe or toxin and the corresponding cell
receptor (neutralization). However, in most cases, antibodies activate and direct other host
defense components, such as complement, against the microbial invader. Antibodies opsonize
microbes to facilitate phagocytosis, form large antigen-antibody complexes (agglutination),
and induce antibody-dependent cellular cytotoxicity (Moore et al., 2001). B cells also act as
antigen presenting cells (Delves and Roitt, 2000b). Moreover, so called T-independent
antigens, like LPS in the bacterial cell wall, directly activate B cells without the need for T
cell help (Moore et al., 2001).
Activation of the adaptive immunity requires a complex interplay between lymphocytes and
other cell types (Moore et al., 2001). For example, antigen presenting cells, such as dendritic
cells and macrophages are essential for the activation of T lymphocytes (Delves and Roitt,
2000b). In addition to the appropriate receptor for antigen recognition on T cells,
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costimulatory signals are needed for activation. These signals include cell surface receptor-
ligand interactions between the T cell and antigen-presenting cell. Moreover, cytokines such
as IL-1, IL-6, IL-12, IL-18 and TNFα can provide costimulatory signals (Delves and Roitt,
2000b; Giacomini et al., 2001). Interestingly, antigen recognition without the appropriate
costimulatory signal leads to T cell anergy or apoptosis. T cell activation and responses are
also regulated by inhibitory signals, which may be either cell surface molecule interactions or
cytokine (e.g. IL-10) -mediated. 
The adaptive host defense possesses a memory, which enables a faster response against the
antigen at subsequent encounters. Adaptive immune responses depend greatly on the microbe
and its immunogenic structures, the genetic background of the host, and the dose and route of
exposure (Moore et al., 2001). However, induction of these responses requires a substantially
longer time than that needed for innate and non-adaptive responses (Medzhitov and Janeway,
2000). 
2.5 Inflammation
2.5.1 General
Inflammation (or the inflammatory response) is a response to different stimuli including
exposure to chemicals or microbes. As such, inflammation is a rather non-specific response,
as described with the latin terms "calor, rubor, tumor, dolor" (heat, redness, swelling, and
pain). However, there can be great differences in the ability of different substances to induce
inflammation. Cellular responses against different bacterial species vary markedly: alveolar
macrophages are capable of defending the lungs against Staphylococcus (Rehm et al., 1980).
Neutrophils, instead, seem to be crucial for protection against Pseudomonas. Subsequently,
the inflammatory responses (mediators, recruited cells) evoked by microorganisms can be
somewhat different.
 
In the acute inflammatory response, cells of the immune system move into the site of
inflammation (Delves and Roitt, 2000a). Inflammatory mediators produced by affected cells
contract local blood vessels and increase their permeability, leading to fluid extravasation.
Expression of adhesion molecules on the vascular endothelium is up-regulated, and the
neutrophils rolling on the vessel wall adhere to these molecules and pass through the wall. A
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chemotactic gradient of chemoattractive mediators directs inflammatory cells to the affected
site.
Microbial antigens entering the body through the mucosal surface will activate cells in
mucosa-associated lymphoid tissue (Delves and Roitt, 2000b). In the lungs, this kind of
lymphoid tissue is bronchus-associated lymphoid tissue (BALT). BALT is present in the
lungs of children and adolescents, and in adult lungs in different diseases, but not in the
healthy lungs of adults (Tschernig and Pabst, 2000). Responses to intranasal and inhaled
antigens occur in palatine tonsils and adenoids (Delves and Roitt, 2000b). Moreover,
microorganisms in tissue can induce responses in the local lymph nodes. The responses to
antigens that have spread to blood circulation are usually initiated in the spleen. 
2.5.2 Inflammatory cells
In the generation of inflammation, cells located at the site of exposure are in a crucial
position. Important inflammatory cells include macrophages, neutrophils, lymphocytes and
eosinophils. During exposure, the responses of these cells to a major extent determine the
outcome of the inflammatory response.
Macrophages
Alveolar macrophages, within the alveolar surfactant film at the interface between air and
lung tissue, possess high phagocytic and microbicidal potential (Lohmann-Matthes et al.,
1994). In the normal resting animal, alveolar macrophages represent more than 90% of the
lavagable cells in the lungs. They are the most important pulmonary macrophages with
respect to microbial killing. These cells are capable of producing reactive oxygen species
(ROS), such as superoxide anion (O2-), hydrogen peroxide (H2O2), and hydroxyl radical
(OH-). These radicals have an important role in both intracellular and extracellular defense
against microorganisms. Moreover, alveolar macrophages can produce many cytokines such
as TNFα, IL-1, IL-6, IL-8, IL-12, IL-18, interferons, defencins, and nitric oxide (Lohmann-
Matthes et al., 1994; Moller et al., 1996; Vankayalapati et al., 2000). These mediators are also
involved in the antimicrobial activity of the cells. In addition, alveolar macrophages can
produce a wide variety of other products such as enzymes (e.g. lysozyme and collagenases),
biologically active lipids (e.g. thromboxane A2 (TXA2), prostaglandins, and leukotrienes),
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antiproteases and other inhibitors, fibronectin, complement components (e.g. C2 and C4),
binding proteins (e.g. transferrin), free fatty acids, antioxidants (glutathione), and coagulation
factors (Sibille and Reynolds, 1990).
Pulmonary macrophages also include interstitial macrophages, which are located in the lung
connective tissue (Lohmann-Matthes et al., 1994). These cells have partly different functional
properties than alveolar macrophages. Even though Fc-receptor-mediated phagocytosis is
equally effective, Fc-receptor-independent phagocytosis and the capability to produce
inflammatory mediators and oxygen radicals is weaker in the interstitial than in alveolar
macrophages. Instead, antigen presentation via MHC II molecules is more effective in
interstitial cells. The alveolar and interstitial macrophages derive from blood monocytes
recruited into the lungs, and they can also locally proliferate in the alveoli or interstitium. 
Intravascular macrophages are located on the endothelial cells in the blood capillary lumen.
They are highly phagocytic and thus differ from monocytes. These cells are believed to
remove foreign and damaging material from the bloodstream. This type of pulmonary
macrophages has been observed in humans but not in rodents (Lohmann-Matthes et al., 1994).
Dendritic cells
Dendritic cells are located in small numbers in the lung interstitial tissue (Lohmann-Matthes
et al., 1994). Their role in tissues is to capture antigens and microbes and after being activated
leave the peripheral tissue and locate into the local lymph node, where they function as
antigen-presenting cells.
Neutrophils
Chemokines released by alveolar macrophages recruit monocytes and neutrophils from the
circulation to the site of inflammation (Stockley, 1995). Neutrophils can produce a variety of
different substances, such as lipids (leukotrienes, platelet activating factor (PAF), TXA2),
cytokines (IL-1β, IL-6, IL-8, TNFα), proteases (elastase, collagenase), microbicidal products
(lactoferrin, myeloperoxidase, lysozyme), ROS, and NO (Sampson, 2000). In addition to
being important phagocytic cells against respiratory pathogens, neutrophils may also have
destructive effects on lung cells and interstitial tissues (Stockley, 1995; Sampson, 2000). One
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culprit of these harmful effects is the proteolytic enzyme, neutrophil elastase, which is
released when the activated neutrophil phagocytizes microbes (Stockley, 1995). Neutrophil
elastase causes excess mucus production, inhibits ciliary function, impairs phagocytic
microbial clearance, and stimulates chemokine production. These effects may delay microbial
clearance, and cause excess neutrophil recruitment into the lungs. Moreover, elastase can
activate eosinophils and mast cells (Sampson, 2000).
Lymphocytes
Lymphocytes (see 2.4.3) are crucial when the capacity of the innate host defense is
overwhelmed and also in hypersensitivity reactions. 
Eosinophils
Eosinophils are bone marrow derived granulocytes, which are present in tissues and blood in
very low numbers (Weller, 1997). However, their number is increased in allergic diseases and
parasitic (helminth) infections. Eosinophils have been considered to be especially important
cells in asthmatic airway inflammation (Sampson, 2000). They can produce cytotoxic basic
proteins (e.g. eosinophil cationic protein, eosinophil peroxidase, major basic protein) and lipid
mediators including cysteinyl leukotrienes that provoke airflow obstruction and bronchial
epithelial damage. Moreover, eosinophils can produce PAF and TXA2. 
Mast cells and basophils
Mast cells and basophils are important cells in IgE-mediated allergic reactions and the
defense against certain parasitic infections, since they bind IgE antibodies efficiently with
specific receptors and subsequently release biologically active mediators such as histamine
and cytokines (Abraham and Arock, 1998; Kurup et al., 2000). The activated cells can also
produce leukotrienes and prostaglandins. In addition to being involved in IgE-mediated
adaptive immune responses there is increasing evidence that these cells, especially mast cells,
contribute also to innate immunity (Abraham and Arock, 1998). Microbes can activate these
cells also via antibody-independent mechanisms.
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2.5.3 Cytokines
Cytokines are small proteins (8 - 40,000 Da) produced by nearly all nucleated cells, which
also respond to them (Dinarello, 2000). These proteins mediate their effects via specific cell
surface receptors in immune or non-immune cells, and they are necessary for the full
development of innate host defense responses and transition to adaptive immunity (Strieter et
al., 2002). Cytokines can have both paracrine and autocrine effects (Kelley, 1990), and they
can provoke (e.g. via TNFα and IL-1) or suppress inflammation (e.g. via IL-10) (Dinarello,
2000). Chemokines can recruit neutrophils and other leukocytes from blood to the site of
inflammation (Sabroe et al., 2002). Moreover, these cytokines are important in regulating
leukocyte trafficking in normal tissue homeostasis. Out of the wide cytokine network, two
cytokines, TNFα and IL-6, which have been analyzed in this study are described in more
detail.
Tumor necrosis factor α
TNFα is a 17-kDa polypeptide. Its responses are mediated through two distinct receptors, a
constitutive receptor (TNFR1) and an induced (TNFR2) receptor (Luster et al., 1999). TNFα
can stimulate the synthesis of other mediators that then regulate cell differentiation and
growth, antiviral activity, immunomodulation and inflammation. Moreover, it possesses
cytostatic and cytotoxic activities, but these effects are associated primarily with transformed
cell lines and tumor cells, and to a lesser extent with normal cells. TNFα, for example, is
mitogenic to lymphocytes, and it increases the activity of macrophages/monocytes,
neutrophils, lymphocytes, natural killer (NK) cells, and endothelial and epithelial cells
(Barnes et al., 1998; Luster et al., 1999). Moreover, it stimulates the production of several
hormones, such as ACTH and thyroid stimulating hormones (Luster et al., 1999). 
TNFα regulates the production of many other inflammatory mediators such as IL-1, IL-6,
IL-8, granulocyte macrophage-colony stimulating factor, and some adhesion molecules
(Barnes et al., 1998; Luster et al., 1999). Thus, many of its apparent effects are not directly
TNFα-mediated (Luster et al., 1999). TNFα may also directly damage pulmonary vascular
endothelium and subsequently cause capillary leakage. TNFα seems to have a dual role in the
lungs. Low levels of the cytokine are present in the normal lungs, and under such conditions it
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may also have a protective role via induced expression of a potent antioxidative enzyme,
superoxide dismutase. However, elevated levels of TNFα in lung fluids have been associated
with many inflammatory lung diseases, such as chronic bronchitis, prolonged cough, bacterial
pneumonia, adult respiratory distress syndrome, cystic fibrosis and asthma (Dehoux et al.,
1994; Barnes et al., 1998; Jatakanon et al., 1999; Luster et al., 1999). Moreover, elevated
levels of this cytokine have been observed during pathological conditions resulting from
environmental exposure, including pollutant-induced inflammatory disease (e.g. caused by
grain and swine dust, coal-mine dust, quartz and asbestos), hypersensitivity pneumonitis and
occupational asthma (Vanhee et al., 1995; Driscoll et al., 1997; Von Essen, 1997; Wang et al.,
1997; Luster et al., 1999). Alveolar macrophages have been suspected to be the major source
of TNFα in the lungs, but it is produced by several cell types, including lung endothelial and
epithelial cells, T lymphocytes and mast cells (Barnes et al., 1998; Luster et al., 1999).
Interleukin-6
IL-6 is a glycoprotein mediator which is produced by a wide variety of cells including
monocytes/macrophages, T and B cells, fibroblasts, mast cells, endothelial cells, and tumor
cells (Kelley, 1990; Van Snick, 1990; Barnes et al., 1998). It can induce B cell differentiation
to antibody forming plasma cells, and augment antibody production (Hirano et al., 1986;
Kelley, 1990; Barnes et al., 1998). It is also involved in T cell growth, differentiation, and
activation (Barnes et al., 1998). It increases T cell proliferation, presumably via increased
IL-2 receptor expression (Van Snick, 1990). IL-6 production is induced for example by a
Gram-negative bacterial cell wall component, LPS, and other inflammatory mediators such as
TNFα and IL-1. It has synergistic effects with IL-1. On the other hand,
IL-6 may also have anti-inflammatory effects, since it decreases TNFα and IL-1 production in
macrophages (Barnes et al., 1998). It may also decrease neutrophil influx into the airways.
IL-6 is produced in asthma and bacterial pneumonia (Dehoux et al., 1994; Barnes et al.,
1998). Exposure to organic or mineral dusts (grain and swine dusts, and coalmine dust)
increase the cytokine level in the lungs (Vanhee et al., 1995; Von Essen, 1997; Wang et al.,
1997). There is some evidence that excessive production of IL-6 may induce polyclonal B cell
activation leading to hypergammaglobulinemia and autoantibody production (Van Snick,
1990). Moreover, overproduction of IL-6 has been implicated in some localized proliferative
diseases.
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IL-6 and TNFα have also systemic effects. IL-6 in blood induces production of the acute
phase proteins (e.g. C-reactive protein, serum amyloid A, α1-chymotrypsin, and fibrinogen),
whereas it down-regulates albumin production in the liver (Kelley, 1990). TNFα also induces
production of the proteins, even though it does not affect as many proteins as IL-6 (Van
Snick, 1990). Both TNFα and IL-6 are endogenous pyrogens that can cause fever (Luheshi
and Rothwell, 1996).
2.5.4 Nitric oxide
Nitric oxide is a free radical and an important mediator, which is produced from L-arginine
via an enzymatically catalyzed process (Singh and Evans, 1997). The enzymes that produce
NO have been divided into two classes depending on their special features: constitutive and
inducible NO synthases. Constitutive forms (cNOS) include neuronal NOS (nNOS) and
endothelial NOS (eNOS) that are continuously expressed in these cells. These enzymes can
produce relatively small amounts of NO, and this NO production is involved for example in
non-adrenergic and non-cholinergic (NANC) neurotransmission and regulation of blood
circulation. Expression of the inducible form of the enzyme (iNOS) is evoked only by the
appropriate stimuli, but iNOS can produce relatively high amounts of the radical. NO
produced by iNOS is involved in host defense against infection and inflammatory diseases of
the airways (Barnes et al., 1998). At least macrophages and epithelial cells can express iNOS
in the lungs (Asano et al., 1994; Singh and Evans, 1997). NO has a short half-life, and it
decomposes rapidly to nitrite (NO2-) and nitrate (NO3-) (Singh and Evans, 1997). However, it
can also combine with the superoxide anion (O2-) and form peroxynitrite (OONO-), which has
toxic effects on many molecules, including nucleic acids, lipids and proteins.
Recently it has been shown that human macrophages produce NO in several inflammatory
conditions, including tuberculosis, rheumatoid arthritis and malaria (Fang and Vasquez-
Torres, 2002). NO plays a role in antimicrobial host defense also against extracellular
pathogens in human as well as in murine macrophages (Hickman-Davis et al., 2002; Fang and
Vasquez-Torres, 2002). Inducible NOS expression has been detected in human alveolar
macrophages and airway epithelial cells during interstitial pneumonia in adults (Lakari et al.,
2002). Increased concentrations of NO in exhaled air, representing the fraction produced in
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the lower airways, have been observed in several inflammatory diseases, including asthma,
lower respiratory tract infection, bronchiectasis and chronic obstructive pulmonary disease
(Alving et al., 1993; Kharitonov et al., 1994; Kharitonov et al., 1995; Maziak et al., 1998).
Exhaled NO level can be elevated also during IgE-mediated allergy (Adisesh et al., 1998;
Henriksen et al., 1999).
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3 AIMS OF THE PRESENT STUDY
The overall aim of the study was to investigate experimentally in vivo the inflammatory and
toxic responses induced by certain microbes isolated from indoor air of moisture-damaged
buildings. The effects of Streptomyces californicus (I and V), Mycobacterium terrae (II),
Aspergillus versicolor (III), and Penicillium spinulosum (IV) were studied after airway
exposure in mice.
The more specific goals of the present study are:
(I - IV) to compare the effects and responses caused by microbial exposure in the
lungs.
(I - V) to evaluate whether the airway exposure can provoke systemic effects.
(V) to compare the responses induced by S. californicus after repeated or single
dose of the microbe.
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4 MATERIALS AND METHODS
4.1 Animals (I - V)
SPF-quality (free of specific pathogens) male NIH/S mice were used in all studies. The
animals were obtained from the breeding colony of the National Public Health Institute,
Division of Environmental Health, Kuopio, Finland. They were transferred from the barrier
unit to a conventional animal room and housed singly in metal cages on aspen wood chips
(FinnTapvei, Finland) one week before the experiments. Animals received water and food
[R36 Maintenance Diet for rats and mouse (Lactamin, Stockholm, Sweden)] ad libidum. The
mice were on a 12-h light/dark rhythm (7 a.m. to 7 p.m.) at the average room temperature of
21-22°C, and relative humidity ranging from 26-47%.
4.2 Microbes (I - V)
Four microbial species were selected: 1) Streptomyces californicus, 2) Mycobacterium terrae,
3) Aspergillus versicolor, and 4) Penicillium spinulosum (Table 4). These species were
selected, since they are typically found microbial species in indoor air of moisture-damaged
buildings. 
Table 4. The microbial species studied.
Species Microbial type Particle size
Streptomyces californicus Gram-positive bacterium ~ 1 µm spore (Reponen et al., 1998)
Mycobacterium terrae mycobacterium ~ 1 µm cell (microscopy)
Aspergillus versicolor fungus 2.0-3.5 µm spore (Guarro et al., 1995) 
Penicillium spinulosum fungus 3.0-3.5 µm spore (Guarro et al., 1995)
The streptomycetes, Aspergillus and Penicillium species have been frequently observed in the
indoor air of moisture-damaged buildings, and they have been considered to be moisture
indicator microbes (Samson et al., 1994). P. spinulosum is commonly observed also in other
buildings, but in the damaged buildings fungal spore numbers are increased. Mycobacteria are
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a less known microbial species in indoor air exposures in the moisture-damaged buildings
(Andersson et al., 1997). These microbes have had different potential to cause cytokine
production and/or cytotoxicity in mouse macrophages in vitro (Hirvonen et al., 1997a, 1997b,
1997c; Huttunen et al., 2000; Huttunen et al., in press).
 
All the microbial strains were isolated, identified and cultured in the Laboratory of
Environmental Microbiology, National Public Health Institute, Kuopio, Finland. A strain of
Streptomyces californicus (I and V), a mesophilic Gram-positive bacterium, was isolated from
the indoor air of a moldy building, as described by Hyvärinen and co-workers (1993). It was
identified by the DSM identification service (DSM-Deutsche Sammlung von
Mikroorganismen und Zellkulturen, Germany). Mycobacterium terrae (II) was recovered
from the indoor air of a moldy building (Rautiala et al., 1996). The isolate was identified by
gas liquid chromatography of the fatty acids, fatty alcohols and mycolic acid cleavage
products, and by its growth and biochemical characteristics. The isolate was tested to be
negative for a commercially available DNA probe specific for Mycobacterium avium complex
(AccuProbe, Gen-Probe Inc., San Diego, CA) (Torkko et al., 1998). Aspergillus versicolor
(III) and Penicillium spinulosum (IV) were isolated from the indoor air of a moldy building.
The strains were identified morphologically, and the identification was verified by the CBS
identification service (Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands). All
the microbes were cultured on standard laboratory media at appropriate temperature and for
an adequate time (I - V). The microbes were collected, and spore/cell numbers were counted
under epifluorescence or a light microscope. The Gram-negative bacterial lipopolysaccharide
(LPS) (Escherichia coli, serotype 0111:B4, Sigma, USA) was used as a reference agent for
biological responses in the model (I).
The doses of the microbes and the time points for collection of samples (Table 5) were
selected on the basis of the results obtained in our preliminary and completed in vivo
experiments, and the previous in vitro studies. The total volumetric load of the doses, i.e.
physical particle sizes of the spores and cells also affected the dose selection. High volumetric
doses may cause non-specific effects by overloading macrophages (Morrow et al., 1992), and
such effects are not relevant for lower dose exposure. 
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Table 5. The doses and schedules for sampling in A) single dose studies and B) the repeated dose
study.
Strain Dose-response experiments     Time-course experiments
    Dose        Sampling        Dose        Sampling
 (spores or        time     (spores or            times
 cells/animal)     cells/animal)  
A) Single dose experiments
S. californicus 2 × 107   24 h       1 × 108 3h, 6h, 24h, 3d, 7d
     (I) 1 × 108 a     ''
3 × 108     ''
M. terrae 1 × 107     ''       1 × 108 6h, 24h, 3d, 7d, 14d, 21d, 28d
     (II) 5 × 107     ''
1 × 108     ''
A. versicolor 1 × 105     ''       5 × 106 6h, 24h, 3d, 7d, 14d, 21d, 28d
     (III) 1 × 106     ''
5 × 106     ''
1 × 107     ''
1 × 108     ''
P. spinulosum 1 × 105     ''       5 × 106 6h, 24h, 3d, 7d, 14d, 21d, 28d
     (IV) 1 × 106     ''
5 × 106     ''
1 × 107     ''
5 × 107     ''
B) Repeated dose experiment
    Dosing and sampling schedule 
S. californicus 2 × 103            - The dose on days 0, 7, 14, 21, 28, and 35.
     (V) 2 × 105         - Sampling 24 hours after the last dosage.
2 × 107          
a Equal volumetric doses in dose response experiments have been indicated in bold font.
4.3 Instillation (I - V)
Animals were anesthetized with the inhalation anesthetic, sevoflurane (Sevorane, Abbot,
Illinois, USA), and exposed either to the microbial spores/cells or HBSS (carrier control,
Gibco, UK) by intratracheal instillation. To deliver the dose, an anesthetized mouse was
placed at a 66° upward prone posture and the incisors were placed on a wire. The dosing was
performed under visual control by using a cold-light source (KL 1500electronic, Schott,
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Germany) placed against the throat. The nostrils were blocked, the tongue was pulled out, and
the dose (50 µl/animal) was delivered onto the vocal folds with a Finn-pipette tip.
4.4 Surgical preparation and sample collection
4.4.1 Anesthesia and blood samples (I - V)
After the exposure period, the animals were anesthetized with an i.p. injection of
pentobarbital and exsanguinated by cardiac puncture. Cardiac puncture was done after
opening the abdominal cavity and removal of the sternum. Blood was collected and serum
separated (Capiject T-MG, Terumo, MD, USA) for cytokine analyses.
4.4.2 Bronchoalveolar lavage, sample collection and cell counting (I - V)
The tracheas of the animals were exposed and cannulated with polyethylene tubing. At first,
the lungs were lavaged with two portions of sterile modified HBSS (30 ml/kg), three times
with each, and these two portions were combined. Thereafter, to get a greater number of cells,
the lungs were further lavaged with six portions of HBSS as before, and these portions were
combined together. Lavage fluids of the two sets were kept on ice. Cytospin was executed
from the first set of lavages. Slides were fixed in methanol and stained with the May-
Grünwald–Giemsa dye, and cell differentials were defined. Cells were separated from the first
two lavages by centrifugation and the supernatant was centrifuged once more to discard all
red blood cells and cell debris. Lactate dehydrogenase (LDH) concentrations were analyzed in
fresh supernatants. The rest of the supernatants were frozen (-80°C) for analyses of TNFα,
IL-6, albumin and total protein concentrations. 
Cells of the first two lavages were resuspended in 200 µl of modified HBSS and the total cell
number of each sample (cells/ml BALF) was counted by the Trypan blue exclusion method.
The rest of the cell suspension was centrifuged, and after discarding the media, red blood cells
were hemolyzed from the cell pellet by hypotonic shock, and the supernatant samples were
collected for hemoglobin assay. Cells of the other set of lavages were centrifuged, the buffer
discarded and red blood cells hemolyzed. The cells were combined with the surplus cells from
the first set of lavages, pelleted and frozen for later Western blot analyses of iNOS.
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4.4.3 Isolation of cells for flow cytometric analysis (V)
Inflammatory cells in the lungs, spleen and lymph nodes (mediastinal, axillary, brachial, and
both superficial and deep cervical nodes) were analyzed by flow cytometry. The tissues were
dissected, and homogenized to single cell suspension. Erythrocytes were hemolyzed by
hypotonic shock from lung and spleen samples. At the end, the hematopoietic cell
concentration (erythrocytes excluded) of each sample (cells/ml) was counted by the Trypan
blue exclusion method, and the total cell number in each organ was calculated.
4.4.4 Dissection for histopathological analysis (I - V)
The lungs (filled with 10% phosphate buffered formalin), liver, spleen and lymph nodes
(mediastinal (I - V), axillary (II - V), brachial (II - V), and both superficial and deep cervical
nodes (II - V)) were preserved in 10% phosphate buffered formalin for histopathological
evaluation.
4.5 Experimental protocols (I - V)
Both dose-responses and time-courses were studied (I - IV). In dose-response experiments,
the animals were exposed to a single dose of microbes, and the responses were measured 24 h
after the dosing. In the time-course experiments, the responses induced by a single dose at a
one-dose level were studied at 5-7 different time points (Table 5). In the repeated dose study
(V), the dose-response induced by the spores of S. californicus was investigated by exposing
mice to six doses at a 7 day interval (at 3 dose levels beside the control) (Table 5).
4.6 Analyses
The parameters analyzed and their main pathophysiological functions/indications are listed in
Table 6.
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Table 6. Parameters and their main pathophysiological functions/indications.
Parameters Pathophysiological functions/indications
Total cell number and cell differentials Degree/state of inflammation in lungs
Cytokines (TNFα and IL-6) Activation of immunological mechanisms (e.g.
inflammation)
Nitric oxide Initiation of inflammation, cell death
Total protein and albumin Edema, tissue/cell damage
Hemoglobin in BALF Inflammation, tissue damage
Lactate dehydrogenase (LDH) Cell death
Histopathology Degree/state of inflammation, structural damage
Lymphocyte subpopulations Activation of immunological mechanisms,
immunotoxicity
The comet response DNA-damage/genotoxicity
4.6.1 Detection of cytokines (I - V)
Cytokines (TNFα and IL-6) were analyzed from BALF and serum by using the ELISA-
method. Antibody pairs were from R&D Systems (Minneapolis, MN, USA) and analyses
were performed according to the manufacturer’s instructions. Briefly, 96-well microtiter
plates were coated with monoclonal capture antibody, and the cytokine in the samples and
standards were allowed to adhere. In the analyses of BALF samples, the standards were
diluted in Diluent, and in serum analyses in NIH/S mouse serum collected from animals of
our stock. The biotinylated second antibody was used. Streptavidin conjugated horseradish
peroxidase (HRP) was used as a detection reagent, and tetramethylbenzidine (TMB) solution
as a substrate. The absorbances were measured by ELISA reader (iEMS Reader MF,
Labsystems, Finland) at the wavelength of 450 nm.
4.6.2 Western blotting for iNOS (I - V)
Cells were lysed, released proteins were denatured, and samples, protein markers (Bio-Rad)
and positive controls were subjected to sodium-dodecyl sulphate polyacryl amide gel
electrophoresis. The protein amount in each sample was calculated after determination of the
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protein concentration by DC Protein Assay (Bio-Rad, Hercules, CA, USA). Proteins were
then electrophoretically transferred to a nitrocellulose (I) or PVDF (II - V) membrane. After
non-specific binding was blocked with BSA, the membranes were incubated with primary
antibody solution [0.1% Rabbit Anti-iNOS pAb (Transduction Laboratories, USA) in BSA]
for 1 hour. Free primary antibody was removed by washings, and the membranes were
incubated in alkaline phosphatase conjugated second antibody solution [0.1% AP-Goat Anti-
Rabbit IgG (Zymax, Zymed, CA, USA) in BSA] for 1 h. The membranes were washed again
to remove free secondary antibody. Finally, the membranes were developed using 5-bromo-4-
chloro-3-indolyl phosphate disodium (BCIP)/nitro blue tetrazolium (NBT) solution, and the
reaction was stopped by rinsing the membranes in tap water.
4.6.3 Flow cytometric analysis (V)
Approximately 1.5 × 105 lung, spleen or lymph node cells were washed and resuspended in
2% fetal bovine serum (FBS) in HBSS. Nonspecific binding was blocked by CD16/CD32
monoclonal antibody (Fc Block, PharMingen, CA, USA). Then the samples, except the
controls, were stained by PE -conjugated CD45, CY-Chrome -conjugated CD3, and either
FITC -conjugated CD25 or FITC -conjugated CD4 monoclonal antibodies (all obtained from
PharMingen, CA, USA). Control cells were stained with anti-human monoclonal antibodies
(PE -conjugated CD8 (Leu-2a, Becton Dickinson, CA, USA), PerCP -conjugated CD3
(Leu-4, Becton Dickinson), and FITC -conjugated anti-TCR-γ/δ-1 (Becton Dickinson)). The
stained samples were washed and fixed in 1% paraformaldehyde fixative. The samples were
stored at 4°C in the dark until fluorescence activated cell sorter (FACS) analysis.
Cells were analyzed by using a FACScan flow cytometer (Becton Dickinson, CA, USA) and
CellQuest analysis program (Becton Dickinson). Forward light scatter, side light scatter, FL1
(FITC), FL2 (PE) and FL3 (CY-Chrome) were used. A total of 25,000 ungated events were
collected from lung samples, and 10,000 events from spleen and lymph node samples. The
proportions of both CD3+ and CD4+ cells within the CD45+ population in the lymphocyte gate
were measured. Total activated and non-activated T cells, and cell numbers of other
populations were calculated by multiplying the calculated total cell number in each organ
(lung, spleen and lymph nodes) with the proportion of the corresponding cell population from
CD45+ cells.
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4.6.4 LDH, total protein, albumin and hemoglobin analyses (I - V)
Lactate dehydrogenase (LDH) concentration in BALF was analyzed by Cytotoxicity
Detection Kit (Boehringer Mannheim, GmbH, Germany) with minor modifications. The
absorbances were measured by ELISA reader at the wavelength of 492 nm.
Total protein concentration in BALF was determined by the modified Lowry method, DC
Protein Assay (Bio-Rad, Hercules, CA, USA). The absorbances were measured by ELISA
reader at the wavelength of 690 nm.
The albumin concentration in BALF was at first analyzed by the modified Doumas
colorimetric method (Procedure No. 631, Sigma, USA) (I). The absorbances were measured
at the wavelength of 628 nm (Philips PU 8750, Great Britain or Shimadzu UV-1201, USA).
To improve the specificity and sensitivity, albumin levels were later analyzed by the ELISA-
method (II - V). Antibody pairs were from Bethyl Laboratories (Montgomery, TX, USA) and
analyses were done according to the manufacturer’s instructions. Briefly, 96-well microtiter
plates were coated with monoclonal capture antibody, and the albumin in the samples and
standards were allowed to adhere. BALF samples (1:900) and the standards were diluted in
Diluent. HRP-conjugated second antibody was used. TMB solution was used as the substrate.
The absorbances were measured by ELISA reader at the wavelength of 450 nm. 
Hemoglobin concentrations in the supernatants of hemolyzed cell pellets were analyzed by
using the modified colorimetric Stadie method (Procedure No. 525, Sigma, USA). Shortly,
when samples mixed with Drabkin’s reagent, and methemoglobin standards were incubated in
96-well plate, the absorbances were measured by ELISA reader at the wavelength of 540 nm.
Hemoglobin concentrations were expressed as µg/ml BALF.
4.6.5 Histopathological analysis (I - V)
Tissue samples from lungs, lymph nodes, spleen and liver of non-lavaged mice, stored in 10%
buffered formalin were trimmed, dehydrated, embedded in paraffin, cut into 5 µm sections
and stained with hematoxylin and eosin. Histopathological changes were evaluated with a
light microscope. 
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In the M. terrae study (II), to evaluate the mycobacterial infiltration especially in the lungs,
sections including the left lung and the spleen from three animals per each group in the time-
course experiment were stained for mycobacteria with standard Ziehl-Neelsen or Auramine-
Rhodamine. Infiltration was subjectively graded as none, scattered, moderate, strong and very
strong from Ziehl-Neelsen stained sections under the light microscope. Identification of the
mycobacteria was confirmed from Auramine-Rhodamine stained sections under fluorescence
microscopy. 
4.6.6 Genotoxicity (V)
Genotoxicity was analyzed by using the alkaline Single Cell Gel (SCG) Assay to measure
DNA damage in blood leukocytes. Determination of DNA damage with the SCG assay was
done according to Singh et al. (1988) with some modifications. Briefly, a whole-blood sample
was spread in low-melting agarose on a microscope slide covered with normal-melting
agarose. The cells were lysed, and electrophoresis was performed. After neutralization, the
slides were stained with ethidium bromide and analyzed by using an automated image
analysis system (Komet 4.0.2., Kinetic Imaging Ltd, UK). The comet response parameters
used in the statistical analysis of the data were tail DNA (tail%DNA), tail extent moment (tail
length × tail%DNA/100), Olive tail moment [(tail mean - head mean) × tail%DNA/100] and
tail length.
4.6.7 Statistical analysis (I - V)
The normally distributed data, with equal variances between the groups, were assessed using
analysis of variance (ANOVA) and Dunnett’s test: exposed groups were compared to carrier
control group. In case the variances were unequal, ANOVA and Dunnett’s C tests were used.
Otherwise Kruskall-Wallis and Dunn’s tests were performed. The difference was considered
significant at p < 0.05.
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5 RESULTS
5.1 Cytokine responses (I - V)
All the tested microbes enhanced TNFα and IL-6 production into bronchoalveolar lavage
fluid (BALF) after a single microbial dose. However, there were marked differences in the
time-courses of the responses, and in potency of the microbes to provoke the cytokine
production. 
TNFα in BALF (I - IV)
At equivalent volumetric doses, the most intense rapid TNFα response was induced by S.
californicus (Fig. 1A). The cytokine level was more than 13 times higher in the S. californicus
group than in the control group at 6 hours after the instillation. M. terrae provoked a rather
similar acute response, the mean concentration being 83% of the response caused by
S. californicus. The TNFα response induced by M. terrae was biphasic, including an intense
acute phase and a sustained phase that lasted over 14 days. The major elevations in TNFα
levels provoked by the other microbes had disappeared within 3 days. The spores of
A. versicolor caused a rapid TNFα response, which appeared later than the responses induced
by the other microbes. The response of A. versicolor peaked at 24 hours, and at the equal
volumetric dose (5 × 106 spores), the response was almost 7-fold compared to the controls.
P. spinulosum exposure provoked an over 8-fold increase in the TNFα level at 6 hours, but
the response disappeared faster than the responses caused by the other microbes.
The 24 h time point in dose-response experiments was a compromise for several of the
parameters, and was not optimal for comparison of microbe-induced TNFα responses.
However, it revealed that already the dose of 1 × 106 spores of A. versicolor induced TNFα
production (Fig. 1B). Both fungal species caused a very strong TNFα response at the highest
dose level (A. versicolor 1 × 108 spores; P. spinulosum 5 × 107 spores), but the volumetric
doses were large due to greater particle size of the spores compared to the bacteria, and it is
possible that the volume exceeded the limit of overloading (see Discussion 6.1).
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In consideration of both the dose-responses and the time-courses, the potency order and the
lowest particle doses to cause TNFα responses were: S. californicus (1 × 108 spores) and
M. terrae (1 × 108 cells) with approximately equal potency. The highest doses of A. versicolor
and P. spinulosum were excluded from the evaluation, because they were in the range of the
overloading dose (see 6.1). S. californicus caused severe inflammation already at the lower
exposure level, whereas M. terrae provoked a sustained response. A. versicolor (1 × 106
spores) had approximately an equal potency with P. spinulosum (5 × 106 spores) to evoke the
TNFα response. At equal volumetric doses, the fungal species had a lower potency to induce
the TNFα response than the bacteria.
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Figure 1. Time-course (A) and dose-response (at 24 hours) (B) of the relative TNFα concentrations in
bronchoalveolar lavage fluid (BALF) after the instillation of a single dose of microbial spores or cells.
The mean concentrations of the carrier control groups have been set to 100% (ctrl level). S.c. = S.
californicus; LPS = lipopolysaccharide; u.c. = untreated control. Asterisk indicates a statistically
significant difference from the control group in the original data (p < 0.05). (I - IV)
S. californicus  (108)
M. terrae (108)
A. versicolor  (5×106)
P. spinulosum  (5×106)
0
200
400
600
800
1000
1200
1400
1600
3h 6h 24h 3d 7d 14d 21d 28d
Time after instillation
R
el
at
iv
e 
T
N
F
α
 
co
nc
en
tr
at
io
n 
in
 B
A
LF
 (%
)
Time-course
control level
Dose-Response
Bacteria Fungi
S. californicus
0
100
200
300
400
500
600
700
800
900
1000
R
el
at
iv
e 
T
N
F
α
 
co
nc
en
tr
at
io
n 
in
 B
A
LF
 (%
)
M. terrae
S.c.
2×107
S.c.
108
S.c.
3×108
LPS
   50 µg
u.c. 107 5×107 108
ctrl
level
P. spinulosumA. versicolor
ctrl
level
 3130
105 106 5×106 107 5×107
 1238
105 106 5×106 107 108
A
B
48
IL-6 in BALF (I - IV)
S. californicus clearly induced the highest IL-6 levels in BALF at equal volumetric doses
(Fig. 2A). This response peaked later than the TNFα response by the same microbe. At 24
hours after the dosing, the IL-6 level was over 20 times higher than that seen in the control
group. The other microbes were less potent, and their IL-6 responses peaked earlier, already at
6 hours (Fig. 2A). A. versicolor exposure caused the next strongest effects (Fig. 2A and 2B).
The IL-6 response was massive at the dose level 1 × 108 spores of A. versicolor. P.
spinulosum and M. terrae caused the weakest IL-6 responses, but the response provoked by
P. spinulosum had subdued already by 24 hours (Fig. 2A and 2B).
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Figure 2. Time-course (A) and dose-response (at 24 hours) (B) of the relative IL-6 concentrations in
bronchoalveolar lavage fluid (BALF) after the instillation of a single dose of microbial spores or cells.
The mean concentrations of the carrier control groups have been set to 100% (ctrl level). S.c. = S.
californicus; LPS = lipopolysaccharide; u.c. = untreated control. Asterisk indicates a statistically
significant difference from the control group in the original data (p < 0.05). (I - IV)
Based on the similar assessment as for TNFα, the rank order of the microbial potential to
provoke IL-6 response in the lungs was: S. californicus (2 × 107 spores), A. versicolor
(1 × 106 spores), and then M. terrae (1 × 108 cells) and P. spinulosum (5 × 106 spores) with an
approximately equal potency. 
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TNFα and IL-6 in BALF after repeated dosing (V)
After repeated dosing of the spores of S. californicus (2 × 103, 2 × 105, and 2 × 107 spores) no
changes were observed in TNFα or IL-6 levels in BALF at 24 hours after the last (6th) weekly
dosage.
TNFα and IL-6 in serum (I - V)
Serum TNFα and IL-6 levels were analyzed to study whether microbial exposure in the lungs
resulted in a systemic cytokine response. Cytokine concentrations in serum were markedly
lower than in BALF. The levels were frequently below the detection limits of the assays. A
single dose of S. californicus (1 × 108 and 3 × 108 spores) increased slightly IL-6 levels at 24
hours (I). Both cytokines peaked at 6 after the instillation of 1 × 108 spores, concomitantly
with the elevated concentrations in lungs. The cytokine responses were not detectable at lower
microbial dose, even after repeated dosing of S. californicus (V). From the other microbes,
only A. versicolor affected the cytokine levels in serum (III). The highest dose (1 × 108
spores) increased the IL-6 level at least 24-fold as compared to controls at 24 hours after the
dosing, whereas smaller doses of this microbe did not affect the cytokine levels. LPS (50 µg),
a positive control, increased serum cytokine levels, especially that of IL-6.
5.2 Expression of inducible nitric oxide synthase (I - V)
Inducible NOS was expressed in BAL cells after S. californicus and M. terrae exposure,
whereas exposure to A. versicolor or P. spinulosum did not provoke any detectable iNOS
expression in lavaged cells. The time-course of the iNOS response was very different between
the bacterial strains. Inducible NOS protein was detectable at 24 hours after S. californicus
exposure (I), whereas exposure to M. terrae did not cause the response before day 7, and the
protein was detectable up to 28 days (II). 
Even though the lowest dose of S. californicus (2 × 107 spores) induced iNOS expression after
a single dose (I), surprisingly the expression was not detectable after repeating the same dose
(V).
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5.3 Inflammatory cell responses (I - V)
The microbes increased the total number of inflammatory cells in BALF though their potency
and the time-course were different. At the equal volumetric doses, S. californicus provoked
the highest increase of inflammatory cells (Fig. 3A and 3B). In addition, already the lowest
dose (2 × 107 spores) caused the maximum, i.e. over 6-fold increase in the total cell number in
BALF (Fig. 3B). Neutrophils were the most typical cells for the acute inflammatory cell
response at 24 hours, macrophages peaked at 3 days, and lymphocytes at 7 days (I). The
lowest dose (2 × 107 spores) caused the highest lymphocyte numbers, at 24 hours. LPS
recruited neutrophils but not lymphocytes or macrophages into the airways at 24 hours.
When compared at equal volumetric doses M. terrae provoked the second strongest response,
which was biphasic (Fig. 3A). The acute inflammatory cell response peaked at 24 hours, the
cell number remained elevated thereafter, and the second phase appeared from 7 days (Fig.
3A). The strength of the acute response by M. terrae was about one-third of that caused by
S. californicus. The cell numbers were still increased even on day 28, contrary to the
responses provoked by the other microbes. In the acute phase, these excess inflammatory cells
were mainly neutrophils, whereas macrophages and lymphocytes were the predominant cells
in the later phase (II). The mycobacterium exposure provoked also an exceptionally long
neutrophil response, which lasted for up to 21 days. 
A. versicolor caused recruitment of inflammatory cells into the airways dose-dependently
beginning at the dose 1 × 106 spores.  At that dose, the total cell number was 32% above the
control level (Fig. 3B). When equal volumetric doses were compared, the A. versicolor
induced cell response was 34% of that caused by S. californicus (Fig. 3A). The highest dose
(1 × 108) caused a drastic inflammatory cell flow into the airways. Again, neutrophils were
responsible for the acute increase of inflammatory cells at 24 hours, macrophages peaked at 3
days, and lymphocytes at 7 days (III). Thus, the pattern resembled that induced by a single
dose exposure of S. californicus (I). However, none of the A. versicolor doses increased
lymphocytes at 24 hours (III). P. spinulosum caused only minor inflammatory cell responses
even at the highest dose level (Fig. 3A and 3B). The increase in inflammatory cells was
mainly due to neutrophils (IV). 
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None of the exposures recruited eosinophils into the airways after a single dose.
Figure 3. Time-course (A) and dose-response (at 24 hours) (B) of the relative total cell numbers
in bronchoalveolar lavage fluid (BALF) after the instillation of a single dose of microbial spores or
cells. The mean concentrations of the carrier control groups have been set to 100% (ctrl level). S.c. =
S. californicus; LPS = lipopolysaccharide; u.c. = untreated control. Asterisk indicates a statistically
significant difference from the control group in the original data (p < 0.05). (I - IV)
The potency order and the lowest particle doses to cause inflammatory cell responses were:
S. californicus (2 × 107 spores) and M. terrae (1 × 108 cells) with an approximately equal
potency. S. californicus provoked a very strong acute response but M. terrae provoked also
the sustained response. A. versicolor (1 × 106 spores) exposure recruited inflammatory cells
into the airways more efficiently than P. spinulosum (5 × 106 spores) exposure. Based on
volumetric doses, the fungal species had lower potency to evoke an inflammatory cell
response than the bacteria.
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Repeated dosing of 2 × 107 spores of S. californicus caused a major recruitment of
inflammatory cells into the airways, the total cell number was over 18-fold compared with the
control (V). The inflammatory cell response consisted mainly of neutrophils and
macrophages. Moreover, the mean lymphocyte number was 9-fold in the spore-exposed
group. The dose of 2 × 105 spores increased the mean total cell number by 29 %. This was
mainly due to the increased numbers of macrophages. Eosinophils were only occasionally
observed in BALF. The lowest dose (2 × 103 spores) did not increase the numbers of
inflammatory cells in BALF.
Red blood cells in BALF may indicate severe increase in vascular permeability and/or
vascular damage. Single doses of S. californicus (2 × 107, 1 × 108 and 3 × 108 spores)
increased equally well the hemoglobin concentration in BALF at 24 hours (I). The effect was
transient, being detectable already at 6 hours but had disappeared by 3 days. Also
A. versicolor provoked red blood cell leakage into airways, but the effect was detectable only
at the highest dose (1 × 108 spores) at 24 hours (III). LPS (50 µg) elevated the hemoglobin
concentration at 24 hours (I). Neither repeated dosing of the spores of S. californicus nor
single dosing of the other microbial species caused any marked increases in red blood cell
leakage into the airways (II, IV and V).
5.4 Albumin, total protein and LDH (I - V)
Albumin in BALF may indicate increased vascular leakage due to inflammation or vascular
damage. The strongest response was provoked by M. terrae: albumin in BALF was on the
increase from 24 hours and peaked at 14 days after bacterial exposure (Fig. 4A).
S. californicus caused the most rapid albumin response in the airways, in 6 hours and it lasted
over 24 hours (Fig. 4A). A. versicolor induced a slower response than the bacterial species,
and its intensity was similar to that evoked by S. californicus, but it lasted for a longer time.
P. spinulosum exposure caused the mildest changes in the albumin level in BALF (Fig. 4A
and 4B).
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Figure 4. Time-course (A) and dose-response (at 24 hours) (B) of the relative albumin
concentration in bronchoalveolar lavage fluid (BALF) after the instillation of a single dose of
microbial spores or cells. The mean concentrations of the carrier control groups have been set to 100%
(ctrl level). S.c. = S. californicus; LPS = lipopolysaccharide; u.c. = untreated control. Asterisk
indicates a statistically significant difference from the control group in the original data (p < 0.05). (I -
IV)
The potency order and the lowest particle doses to cause the observed albumin responses
were: M. terrae (1 × 108 cells), then S. californicus (2 × 107 spores) and A. versicolor
(1 × 106 spores) with approximately equal potency, and then P. spinulosum (5 × 106 spores).
The dose of 2 × 107 spores of S. californicus caused a significant albumin leakage into the
airways after repeated dosing (V). 
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The increased total protein in BALF is indicative of tissue/cell damage and/or vascular
leakage. The total protein levels resembled the albumin levels in BALF suggesting that the
majority of the protein was albumin, which had leaked from pulmonary capillaries (Fig. 5A
and 5B). Again, the mycobacterium exposure provoked a sustained response, and the highest
levels were observed as late as on 14 and 21 days. S. californicus and A. versicolor caused
transient responses. P. spinulosum exposure had only minor effects on the total protein level
in BALF.
Based on similar assessment, the potency order and the lowest particle doses to cause
observed increase in total protein level in BALF were: M. terrae (1 × 108 cells), then
S. californicus (2 × 107 spores) and A. versicolor (1 × 105 spores) with approximately equal
potency, and then P. spinulosum (5 × 107 spores).
The 2 × 107 spores of S. californicus provoked a similar increase in the total protein level in
BALF after repeated dosing (V) as 1 × 108 spores after a single dose (I). The lower doses did
not affect total protein levels in BALF after repeated dosing.
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Figure 5. Time-course (A) and dose-response (at 24 hours) (B) of the relative total protein
concentrations in bronchoalveolar lavage fluid (BALF) after the instillation of a single dose of
microbial spores or cells. The mean concentrations of the carrier control groups have been set to 100%
(ctrl level). S.c. = S. californicus; LPS = lipopolysaccharide; u.c. = untreated control. Asterisk
indicates a statistically significant difference from the control group in the original data (p < 0.05). (I -
IV)
LDH was measured as an indicator of increased cell death in lungs. Acute increases of LDH
in BALF were observed during S. californicus, M. terrae and A. versicolor exposure (Fig. 6A
and 6B). M. terrae provoked the strongest and also a sustained response, which lasted to the
end of the experiment. P. spinulosum did not cause any marked cytotoxicity at any dose or
time point studied. 
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Figure 6. Time-course (A) and dose-response (at 24 hours) (B) of the relative lactate
dehydrogenase (LDH) concentration in bronchoalveolar lavage fluid (BALF) after the instillation of a
single dose of microbial spores or cells. The mean concentrations of the carrier control groups have
been set to 100% (ctrl level). S.c. = S. californicus; LPS = lipopolysaccharide; u.c. = untreated control.
Asterisk indicates a statistically significant difference from the control group in the original data (p <
0.05). (I - IV)
The potency order in the LDH responses was: M. terrae (1 × 108 cells), S. californicus
(1 × 108 spores), A. versicolor (5 × 106 spores), and P. spinulosum (not toxic).
The LDH level in the group exposed repeatedly to S. californicus (2 × 107 spores) was almost
2.5-fold compared to the controls, though the difference was not statistically significant (V).
The response was greater than that observed after a single dose of the same or even a higher
dose (1 × 108 spores) (I).
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5.5 Histopathological changes (I - V)
Histopathological analysis confirmed the inflammatory changes in the lungs. The spores of
S. californicus caused a strong acute dose-dependent inflammation in lungs after a single
dosage (I). Already 2 × 107 spores caused mild or mild/moderate inflammation at 24 hours.
When the dose was increased to 1 × 108 spores, the inflammation was mild/moderate already
after 6 hours from the instillation, most severe at 24 hours, but mild inflammatory changes
were still seen after 3 days. The histopathological signs of inflammation had elapsed by 7
days. The inflammation induced by the positive control LPS (50 µg) was mild/moderate after
24 hours. Also the carrier buffer caused some mild inflammatory changes.
Neutrophils were the predominant cells in the acute inflammatory changes in the lungs during
M. terrae exposure (II). They increased dose-dependently at 24 hours. Macrophages and other
mononuclear cells were increasingly present in alveolar and partly in the bronchiolar spaces
on day 3, and their occurrence in alveoli was increased for up to 28 days after exposure to
M. terrae (1 × 108 cells). Mononuclear cells, such as lymphocytes and macrophages were
typically seen peribronchiolarly and perivascularly. This response seemed to be the most
severe on days 14 and 21. Based on mycobacterial staining, mycobacteria were present in
lungs at least till 28 days after a single bacterial dose. The highest levels were observed at 24
hours. Presumably all mycobacterial cells had not yet been phagocytized at 6 hours, and thus
they might have been partly lost during the sample processing. The number of mycobacteria
in the lungs was decreasing from 14 days after the dosing.
The inflammation-related histopathological changes in lungs by A. versicolor were dose-
dependent at 24 hours (III). An increased number of neutrophils was observed above
1 × 105 spores. However, the histopathological changes were mild to moderate with doses
lower than 1 × 108 spores. Neutrophils were the most prominent cells up to 24 hours, whereas
mononuclear cells such as macrophages and lymphocytes were the predominant cells from 3
to 7 days after instillation of 5 × 106 spores. Moreover, few animals with granuloma like
formations were detected at these two time points, and peribronchiolar and -vascular
aggregates of lymphocytes were observed at 7 days. Thereafter, the changes were minor, and
all exposure-induced changes had disappeared by 28 days. 
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P. spinulosum induced the mildest histopathological changes. However, dose-dependent
neutrophilic inflammation in the lungs was observed with doses higher than 1 × 106 spores at
24 hours (IV). Exposure to 5 × 106 spores induced a neutrophil response that disappeared after
24 hours, and the number of mononuclear cells was slightly increased peribronchially and -
vascularly between 3 and 14 days.
Repeated dosing of S. californicus (2 × 107 spores) induced a moderate to abundant increase
in the numbers of mononuclear cells and neutrophils in the alveoli and in bronchiolar lumen.
The amount of peribronchial and vascular mononuclear cells was also increased. Moreover, in
one out of three mice, these mononuclear cells also created granuloma-like formations. Also
the lowest dose (2 × 103 spores) caused some neutrophil responses, but the mid-dose
(2 × 105 spores) did not cause any histopathological changes.
M. terrae exposure (1 × 108 cells) induced a reactive change, i.e. mild follicular hyperplasia in
lymph nodes associated with the lungs from 14 to 28 days (II). The highest single dose of
S. californicus (3 × 108 spores) cause mild inflammatory changes in mediastinal lymph nodes
at 24 hours (I). Neither A. versicolor nor P. spinulosum caused any clear exposure related
changes in lymph nodes (III and IV). Repeated dosing of 2 × 107 spores of S. californicus
induced reactive changes in lymph nodes, whereas this effect was not observed at the lower
doses of the microbe (2 × 103 and 2 ×105 spores) (V). 
None of the exposures caused any clear exposure related histopathological changes in the
spleen or the liver (I - V).
5.6 Lymphocyte populations in lungs, lymph nodes and spleen (V)
Repeated dosing of the spores of S. californicus affected lymphocyte populations in the lungs,
lymph nodes and the spleen. 
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Lungs
The highest dose of S. californicus (2 × 107 spores) induced the strongest effects in the lungs.
It increased the total cell number by more than five-fold, as well as elevated both the T cell
(CD3+ cells) and the activated T cell (CD3+CD25+) numbers. The number of T lymphocytes
more than doubled and the activated T cells increased by 3.5-fold compared to the control. In
addition, the proportion of activated T cells (CD3+CD25+ cells/CD3+ cells) was clearly higher
(9%) in the spore-exposed group than in the control group. The majority of the T cells were
helper T cells (CD3+CD4+), even though also the CD3+CD4- cell population including killer T
cells (CD3+CD8+) and γδ+ T cells almost doubled at the highest dose level. However, the
greatest lymphocyte cell number was observed in the CD3-CD4- population (includes B
lymphocytes and natural killer cells), the increase in these cells being almost 5-fold. Also the
amount of unconventional CD3-CD4+ lymphocytes increased at the highest dose level more
than 7-fold. Although, the lower spore doses did not markedly affect the cell populations, the
cell numbers tended to be lower at the spore dose of 2 × 105 compared to that of 2 × 103.
Lymph nodes
The strongest increase in the total cell number (41%) in lymph nodes was detected at the
lowest repeated dose of S. californicus (2 × 103 spores). A similar dose-response pattern was
seen in all cell populations. Even though the T cell number increased during the spore
exposure, the proportion of activated T cells remained low. The most notable change in the
cell populations at the lowest spore dose was a 53% increase in the number of CD3+CD4-
cells. The greatest changes induced by the highest spore dose (2 × 107) were the increases in
the total cell number (19%) and the number of activated lymphocytes (18%). The mid-dose
(2 × 105) had only minor effects on the total cell number and cell populations. 
Spleen
The total cell number in the spleen decreased during the repeated exposure to the spores of
S. californicus. This effect was most obvious at the dose of 2 × 105 spores (38% decrease).
The effect was partly reversed by the highest spore dose (2 × 107), when the total cell number
was only 13% below the controls. The numbers of T cells, activated T cells, helper T cells,
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and especially the amount of other T cells (CD3+CD4-) was decreased by all spore doses. The
strongest effect was again detected at the mid-dose (2 × 105 spores), when the decrease varied
between 36% and 52%. The dose of 2 × 103 spores decreased the numbers of CD3+ to a
greater extent than it depressed CD3- cell numbers. The higher doses, especially the mid-dose
(2 × 105 spores) decreased both CD3-CD4- and CD3-CD4+ numbers. Although the changes in
the cell populations in lymph nodes and spleen were not statistically significant, the trends
were clear.
5.7 Genotoxicity (V)
DNA damage assessed by the comet response was not detected in blood leukocytes after
repeated dosing of the spores of S. californicus into the airways.
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6 DISCUSSION
There is convincing epidemiological evidence indicating that moisture-damage in buildings
can provoke adverse health effects. Previous in vitro experiments have also shown that
bacterial and fungal species isolated from moisture-damaged buildings can cause
inflammatory and toxic responses (Hirvonen et al., 1997b; Huttunen et al., 2000; Huttunen et
al., in press). However, the data concerning in vivo effects after experimental exposure in
lungs have largely been missing. There has not been any comparative knowledge on the
potential of different moisture indicator microbes to cause adverse effects. In addition, it has
not been known how well the in vitro experiments can predict in vivo effects. This thesis has
addressed these particular points. 
This is the first time when the inflammatory and toxic potential of the microbes isolated from
moisture-damaged buildings has been compared in a systematic way after airway exposure.
Thus, a mouse model was devised. The responses provoked by S. californicus and M. terrae
have not been previously investigated in vivo at all. Moreover, this is one of the first studies
when systemic effects and the effects after repeated airway exposure of a microbe from
moisture-damaged building have been investigated. 
6.1 Evaluation of the mouse model (I - V)
Airways are presumably the most important route of exposure in occupants of moisture-
damaged buildings. The route of exposure is critical for toxicological evaluation, since for
example, mycotoxins may be more toxic after airway exposure than after per oral dosing
(Creasia et al., 1990). The selected exposure method is also important. In intratracheal
instillation, the dose is accurate. The method has been evaluated to be sufficiently similar to
inhalation exposure, since it has been routinely used in studies on the pneumotoxic potential
of respirable particles (Reasor and Antonini, 2001), even though the particle deposition and
distribution patterns are slightly different from that of the inhalation method (Brain et al.,
1976; Pritchard et al., 1985). Other advantages of the mouse model are that the
immunological system of the mouse is relatively well known, and in vitro findings can be
compared to in vivo observations in the same species.
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Both the dose-response and time-course experiments were considered necessary for the
evaluation of the inflammatory and toxic potential of the microbes. The time-course
experiment indicates the peak and duration of response, and the dose-response experiment
reveals the lowest active dose. However, to reduce the size of the experiments, the time points
for sampling had to be kept reasonable. The time point of 24 hours for the dose-responses was
a compromise between different responses, and therefore, was not optimal for all of the
parameters studied. The acute inflammatory cell responses peaked at 24 hours, whereas the
cytokine responses generally peaked earlier. Although the cytokine responses were still
detectable at that time, the ultimate lowest effective doses could not be observed. 
The dose needs special attention, because microbes are different in their size. The spores are
also vehicles for microbial toxins (Sorenson, 1999) and other active agents which are either
inside the spores or on the cell walls. It has been shown that both viable and nonviable spores
may initiate inflammatory and toxic responses (Hirvonen et al., 1997c; Cooley et al., 2000).
Furthermore, the pure particle effect may contribute to the response observed, and this has to
be taken into consideration when the data are interpreted. Thus, it is relevant to use whole
spores or intact microbes as an exposure. In addition, high doses of particles are known to
cause the overloading phenomenon, i.e. non-specific effects due to physical overloading and
the subsequent excess activation of the macrophages (Morrow, 1992). Responses induced by
such high doses are toxicologically irrelevant and should be distinguished from the other
exposure-induced effects. The dose to cause overloading in rat has been approximated to be
60 µm3/alveolar macrophage, by estimating that there are 5 × 107 activated alveolar
macrophages in rat lungs (Morrow, 1992). The overloading dose for mice is not known but it
was approximated to be the same, and the number of activated alveolar macrophages in
mouse lungs was assumed to be 1/10 of the amount in the rat (5 × 106 cells) (I - IV). 
In this summary, to avoid the contribution of the overloading phenomenon to the comparison
of the microbes, the volumetric dose (the total volume of the particles in the dose) was used as
one criterion of the dose in addition to the particle number. The comparison was made at
doses, which are below the overloading dose. Particle size determines the volumetric dose. In
addition to the volume, the particle size determines conceivable amount of biologically active
components inside the spores or microbial cells. Moreover, the surface area of the dose, i.e.
the conceivable amount of biologically active cell wall structures, is determined by the size of
the particle. As seen in Figure 7, the volumetric doses and surface areas of the microbial doses
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with equal particle numbers may differ markedly. In order to produce truly representative
dose-response curves, also high doses had to be included in the experiments. The calculations
indicated that only the dose of 108 spores of A. versicolor (III) and 5 × 107 spores of
P. spinulosum (IV) exceeded the approximated overload dose. This was, indeed, supported by
biochemical responses, which increased abruptly at these doses. Moreover, the number of
alveolar macrophages decreased, presumably because of overloading induced non-specific
cytotoxicity. As stated, the effects induced by the highest doses of fungal spores were
excluded from the final evaluation of the results (Table 7).
Figure 7. A) Relative volumetric doses and surface areas of the indicated microbial doses.
B) Approximately equal volumetric doses and their surface areas. Particles were suggested to be
spherical, and physical diameters of the spores of S. californicus (S.c.) and M. terrae (M.t.) cells 1
µm, and spores of A. versicolor (A.v.) 2.75 µm and P. spinulosum (P.s.) 3.25 µm.
The overall comparison of the microbes is difficult because both the volumetric dose and the
number of the microbial particles must be taken into consideration. Therefore, the time-course
studies were conducted with equal volumetric doses, and the dose-response studies over a
wide particle number range, and this summary is a synthesis of the data. In the determination
of the effective dose, the whole dose-response data were considered, not only the statistically
significant changes.
6.2 Inflammatory and toxic potential of the microbes after single dosing (I - IV)
All the microbial strains provoked inflammatory changes in the lungs as assessed by
biochemical and cell profile analyses in BALF and these responses were confirmed by
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histopathological analysis. However, the microbes had a different potential to cause
inflammatory and toxic responses, and both the magnitude and the time frame of the
responses were different. Moreover, the duration of the responses clearly differed. Due to
many differences in both microbial particles and induced responses, it is difficult to compare
and arrange the microbes in a rank order according to their inflammatory and toxic potency,
even though this would be useful in risk assessment. Comparison of bacterial and fungal
species separately is easier since both particle numbers and volumetric doses are
approximately equal. However, comparison of the bacteria and fungi was also necessary. 
S. californicus provoked a very strong acute inflammatory response, even at the lowest dose
level (2 × 107) (Table 7). The exposure induced strong and rapid TNFα, IL-6 and iNOS
production, albumin leakage and heavy acute neutrophil infiltration into the airways. Later
increases of macrophages and lymphocytes were also observed in the lungs typically for acute
inflammation. S. californicus was the only microbe, which notably increased red blood cell
flow into the airways. It was not possible to determine whether the spores were toxic to
capillary endothelium or the acute inflammatory response was strong enough to increase red
blood cell flow through the walls of the dilated capillaries. The effect of a single dose had
decayed nearly within a week. The lowest effective single dose level remained unknown since
the lowest spore dose tested resulted in a marked inflammatory response. Based on these
acute responses, S. californicus can be considered as the most potent of these microbes (Table
7). 
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Table 7. Summary of the observed effects and effective doses of the microbes after a single dose.
Response S. californicus
(spores)
M. terrae
 (cells)
A. versicolor
 (spores)
P. spinulosum
 (spores)
 
TNFα in BALF
 
108 a(2×107)b
1.c
108 S (5×107)
1.
106 (105)
3.
5×106 (106)
4.
IL-6 in BALF
  
2×107 (Nd)
1.
108 (5×107)
3.
106 (105)
2.
5×106 (106)
3.
Inducible NOS in
lavaged cells
  
2×107 (N)
1.
108 D (5×107) 
1.
No effect
3.
No effect
3.
Inflammatory
cells in BALF
 
2×107 (N)
1.
108 S (5×107) 
1.
106 (105)
3.
5×106 e (106)
4.
Albumin in BALF
 
2×107 (N)
2.
108 S (5×107)
1.
106 (105)
2.
5×106 (106)
4.
Total protein in
BALF
 
2×107 (N)
2.
108 S (5×107)
1.
105 (N)
2.
No effect
4.
LDH in BALF
 
 
108 (N)
2.
108 S (5×107)
1.
5×106 (N)
3.
No effect
4.
Red blood cells in
BALF
 
2×107 (N)
1.
No effect
2.
No effect
2.
No effect
2.
Histopathology of
lungs
  
2×107 (N)
1.
108 S (5×107)
1.
106 (105)
3.
5×106 (106)
4.
Histopathology of
lymph nodes
3×108 f (108)
1.
108 D (5×107) 
1.
No effect
2.
No effect
2.
IL-6 in blood
 
108 (2×107)
1.
No effect
2.
No effect
2.
No effect
2.
 
Equal volumetric
dose
  
108 108 5×106 5×106
The lowest dose
evaluated
 
 2×107 107 105 105
Doses in the range
of overloadingg 
 
– – 108 5×107
D = Delayed response. S = Acute and sustained response.
a The lowest effective dose.
b No observed effect level (NOEL) in this study.
c Rank order of descending potency.
d The lowest effective dose was below the lowest administered dose.
e Only a minor neutrophil response.
f Only mediastinal lymph nodes were analyzed.
g Excluded from the evaluation of the potency.
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The marked acute inflammatory response caused by M. terrae was manifested at a higher
dose level (1 × 108) than by S. californicus (2 × 107), whereas the inflammatory response was
sustained for a considerably longer time. A single dose of M. terrae caused a biphasic
inflammation which lasted at least for 4 weeks, suggesting that even a short intermittent
exposure may provoke prolonged adverse effects. This was presumably due to the better
ability of mycobacteria to avoid innate host defense mechanisms than the other microbes.
However, intracellular growth of the microbe could not be detected by mycobacterial staining.
Both biochemical and inflammatory cell responses differed between the two phases of the
inflammatory response. Production of TNFα seemed to be associated with IL-6 response only
in the acute phase, and with NO production only in the later phase. TNFα and NO have been
shown to contribute to neutrophil recruitment during M. bovis bacillus Calmette-Guérin
(BCG) exposure in mice (Menezes-de-Lima-Júnior et al. 1997). Thus, these mediators may
have a role in the sustained neutrophil response observed during M. terrae lung exposure.
Moreover, NO has been suggested to be an important factor in the host response against
mycobacteria (Denis, 1991; Flesch and Kaufmann, 1991; Chan et al., 1992). The role of IL-6
is not clear in mycobacterial infections (Kopf et al. 1994; VanHeyningen et al. 1997). 
The inflammatory cell response was also biphasic during exposure to M. terrae. Neutrophils
were the most typical cells in the acute phase, whereas macrophages and lymphocytes were
characteristic of the later phase. T cell-mediated immunity has been shown to be essential in
the host defense against mycobacterial diseases (Holland et al. 1996), which is presumably
one reason for the strong lymphocyte and macrophage responses after M. terrae exposure. In
line with the current finding, sustained biphasic inflammatory response in the mouse lungs
induced by another non-tuberculous mycobacterium, M. bovis BCG has been described earlier
(Menezes-de-Lima et al., 1997). Intratracheal instillation of 105 living cells of M. bovis BCG
provoked a lymphocyte response in the lungs, which peaked at 4 weeks after the dosing
(Fulton et al., 2000). In particular, the neutrophil response was slower after M. bovis BCG
exposure than the response induced by M. terrae. The sustained neutrophil responses in these
studies suggest that neutrophils play a role in controlling non-tuberculous mycobacterial
infections in mice. M. terrae was not acutely very toxic in vivo. However, it caused
significant cytotoxicity especially 2 - 3 weeks after the single dose. This was possibly due to
inflammatory cell-mediated killing of the infected cells, i.e. the cytotoxicity was
inflammation-mediated.
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The lowest exposure level of M. terrae to cause sustained inflammatory response after a
single dose or upon repeated dosing cannot be predicted. Some responses, including
monocyte recruitment and albumin leakage into the airways, were more intense during the
later phase of the inflammation (Table 7). Since dose-response data revealed only the acute
responses, the duration of the inflammation after lower dose exposure is not known. However,
the potential of the mycobacterium to cause sustained inflammation suggests that it is, indeed,
a harmful indoor air microbe.
A. versicolor induced an acute inflammation in the mouse lungs. Previously A. versicolor
exposure has been reported to cause inflammatory changes also in the rat lungs (Sumi et al.,
1994). In that study, production of IL-1β and inflammatory cell recruitment into the lungs
were observed. These findings together indicate that exposure to the spores of A. versicolor
causes production of several proinflammatory cytokines, including TNFα, IL-1 and IL-6. In
line with the current findings, TNFα and IL-6 have been shown to be important components
of the host defense in Aspergillus fumigatus induced inflammation in the mouse lungs
(Mehrad et al., 1999; Cenci et al., 2001). They participate in neutrophil recruitment into
airways, and fungicidal activity of inflammatory cells during exposure to
A. fumigatus spores (Mehrad et al., 1999; Schelenz et al., 1999; Cenci et al., 2001). A single
intratracheal dose of 5 × 106 spores of A. fumigatus induced an inflammatory cell response in
the mouse airways (Hogaboam et al., 2000), even though the response appeared more slowly
than that seen for A. versicolor. The specific feature of the inflammation caused by
A. versicolor was the slower onset of the TNFα response than by the other microbes, and the
inflammation also lasted for a longer time than that induced by another fungus,
P. spinulosum. This may be due to a slower rate of phagocytosis of the spores of
A. versicolor. It has been shown that the spores of A. fumigatus can resist elimination by
producing substances, which have an inhibitory effect on phagocytosis (Robertson et al.,
1987). The results from the present study suggest that A. versicolor may be cytotoxic even
below the level causing a detectable inflammatory response. The cytotoxicity was indicated
by the mild increases in total protein and LDH in BALF. The lowest observed effect level
(LOEL) was 1 × 105 spores (Table 7). The lowest biologically active dose remained unknown
for A. versicolor. It may be considered to have a lower potential to cause inflammation than
S. californicus or M. terrae, when the larger size of the spores and that the fungus did not
induce expression of iNOS or cause long-lasting inflammation were taken into account.
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P. spinulosum was clearly the weakest microbe to induce inflammation and toxic effects after
a single spore dose (Table 7). Even though the cytokine responses were detected, the
inflammatory cell response was modest and the changes disappeared rather quickly.
Presumably the spores were phagocytized and processed further within a rather short time, as
was the case after airway exposure to the spores of Penicillium chrysogenum (Cooley et al.,
1999). Thus, the innate host defense was able to clear the spores without the marked support
provided by the early non-adaptive immune host response. Moreover, P. spinulosum is not
known to produce potent toxins, which may partly explain the observed low toxicity. The
spores of P. chrysogenum have also been shown to increase the production of TNFα in the
mouse lungs after a single intranasal dose (Cooley et al., 1999). Repeated dosing of the viable
spores (6 weekly doses of 104 spores) of P. chrysogenum into the mouse lungs provoked Th2-
cytokine-mediated inflammation, including airway easinophilia and IgE production (Cooley
et al., 2000). No recruitment of eosinophils or lymphocytes into the airways was observed
after a single dosage in the present study. The lowest observed effect level (LOEL) was
5 ×106 spores.
The major differences in the responses between the tested microbial species were their ability
to provoke IL-6 production, induce the expression of iNOS, and cause inflammatory cell
recruitment into the airways. Although all of the microbes tested provoked rapid TNFα and
IL-6 responses, the IL-6 response induced by S. californicus was exceptionally strong. This is
of interest since IL-6 has been suspected to play a critical role in the progress of lung
inflammation/injury induced by exposure to environmental air pollutants (Yu et al., 2002).
The spores of S. californicus also provoked the strongest acute inflammatory cell response.
Recruitment of neutrophils, monocytes and lymphocytes may also contribute to the
appearance of the adverse effects. The differences in IL-6 response and inflammatory cell
recruitment were the most remarkable between S. californicus and P. spinulosum. Even at the
80-fold volumetric dose and 2,5-fold particle dose level, the P. spinulosum exposure
provoked only a mild inflammation compared to the lower dose of S. californicus. The
differences in the inflammatory cell response suggest that these microbes have marked
differences in their ability to induce chemokine production. 
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Although TNFα is an important proinflammatory mediator, and it can induce production of
many other mediators (Barnes et al., 1998; Luster et al., 1999), the observed TNFα responses
in the airways were not necessarily associated with strong IL-6 production, inflammatory cell
response, or expression of iNOS. For example, even though P. spinulosum provoked a
relatively high peak concentration of TNFα, the IL-6 and the inflammatory cell responses
were mild, and iNOS expression was not detected at all. Thus, it is obvious that in addition to
TNFα, several other factors and regulators determined these responses in the mouse lungs
during microbial exposure. Neither fungal species induced iNOS expression even though the
acute cytokine responses were detected. Whether this is a more general difference between
fungi and bacteria remains to be determined.
In the current study, LDH represented one parameter of cytotoxicity. Similarly, the presence
of high total protein levels in BALF may also indicate cytotoxicity. The most of the total
protein responses caused by the studied microbes consisted of albumin leakage from blood.
However, also other proteins were excessively present in the airways during the airway
inflammation. The origin of the other proteins remains unknown, but they may be derived
from dead cells or as an exudant from blood. At least a part of the protein was derived from
dead cells, as indicated by LDH. In severe inflammation, all three parameters (albumin, total
protein, LDH) were increased, but the most sensitive marker was the elevated total protein
level in BALF. Hence, it is not possible to separate "direct" toxicity from the inflammation-
associated changes. However, the time scale of the detected biochemical and inflammatory
cell responses as well as histopathological changes suggest that the major part of changes
indicative of cytotoxicity were inflammation-mediated, this being especially true for
M. terrae.
One important and intriguing question is whether the microbial airway exposure leads to
systemic effects. The exposure to M. terrae, S. californicus, and A. versicolor provoked also
systemic effects after a single dosage. M. terrae caused reactive changes in lymph nodes,
indicating that the inflammatory response was also seen outside the lungs. S. californicus and
A. versicolor induced elevated IL-6 levels in blood suggesting that they may cause also
systemic effects. However, the A. versicolor-induced response was detected only in a very
high volumetric dose (1 × 108 spores).
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6.3 Responses after repeated dosing of S. californicus (V)
Repeated airway exposure to the spores of S. californicus provoked a complex immunological
response. In addition to severe inflammation in the lungs, also a decrease in the amount of the
splenocytes was observed. In lymph nodes, immunostimulation was detected at the lowest
spore dose (2 × 103 spores). The dose response patterns in the spleen, lymph nodes and even
in the lungs resembled each other indicating that the exposure-induced effects were not
limited to the lungs (see V, figures 2 - 4). The severe inflammation in the lungs was observed
at the dose of 2 × 107 spores, and the immunotoxic effect was seen especially in the spleen at
the dose of 2 × 105 spores. 
The immunostimulatory ability of the spores of S. californicus was already known from
previous in vivo and also in vitro studies, but the immunotoxic feature has not been observed
previously. The ability of streptomycetes to produce a wide variety of secondary metabolites,
and special features of some of these substances may explain the observed effects.
Streptomycetes produce several agents used in cancer chemotherapy. These agents include
anthracyclines, such as daunorubicin and doxorubicin (Arcamone, 1998). The toxic effects of
these substances on splenocytes have been demonstrated in several studies (Fornasiero et al.,
1992; Zaleskis et al., 1995; Ferraro et al., 2000). These agents have been shown to cause a
rapid and massive depletion of T and B lymphocytes, especially in the spleen, moderately in
the lymph nodes, and to a lesser extent in thymus, after a single low-level i.p. injection in
mice (Fornasiero et al., 1992; Ferraro et al., 2000). Opposite immunomodulating effects have
been observed also during mycotoxin exposure (Bondy and Pestka, 2000). In addition to
immunostimulation, these agents may also cause immunosuppression. The immunotoxic
effects provoked by some mycotoxins (e.g. gliotoxin, ochratoxin A, trichothecenes) can also
affect the splenocytes.
In summary, these observations suggest that opposing effects may contribute to the responses
induced by the spores of S. californicus. Even the lowest spore dose (2 × 103) induced a weak
but detectable cellular response in the lungs and lymph nodes. The mid-dose
(2 × 105) seemed to abolish the immunological stimulation presumably due to
immunosuppressive or other immunotoxic effects. The highest spore dose (2 × 107) caused
severe inflammation by stimulating both innate and adaptive immune responses in the lungs.
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At this dose, the immunostimulation was also reflected in the reactive changes in the lymph
nodes observed in histopathological analysis. The strong immunological response might
partly overcome the immunotoxic effects on the spores in the spleen and lymph nodes. In
addition, the repeated exposure to S. californicus induced an untypical lymphocyte
subpopulation in the lungs. This could well be a similar population that was observed in the
lungs of the same mouse strain during infection with the intracellular pathogens, Chlamydia
pneumoniae, or influenza A virus (Penttilä et al., 1998).
In this mouse model, the overall no observed effect level (NOEL) after repeated exposure was
below 2 × 103 spores/week, and with respect to the immunotoxic effect in the spleen, the dose
level was below 2 × 105 spores/week. A sufficient dose to cause strong airway inflammation
in mice was between 2 × 105 and 2 × 107 spores/week.
Repeated dosing of S. californicus (2 × 107 spores) provoked a markedly stronger
inflammatory cell response in the airways than that observed in a single dose study at any
tested dose (2 × 107, 1 × 108 or 3 × 108 spores) (I). The cell profiles were rather similar in both
studies: Neutrophils were the most prominent cells in BALF but also macrophages and
lymphocytes were recruited into the airways. Moreover, the total protein, albumin and LDH
responses were stronger after repeated dosing indicating stronger inflammatory and toxic
responses. The albumin and LDH responses induced by 2 × 107 spores in the repeated dose
study were even stronger than the responses provoked by 1 × 108 spores in the single dose
study (I). 
However, not all of the responses were stronger after repeated dosing of the spores. IL-6
response seemed to be weaker or more transient after repeated dosing than after single dosing
of S. californicus. In addition, iNOS expression was not detectable after repeated dosing.
These differences may be due to a change from an acute inflammation to a more chronic type. 
The effects after repeated dosing of the spores of S. californicus occurred at the same level of
exposure (based on spore numbers) as seen with toxic spores of Stachybotrys chartarum in
the mouse lungs (Nikulin et al., 1997). Stachybotrys chartarum is one of the most widely
studied toxigenic fungus of the moisture-indicator microbes. Repeated intranasal dosing of
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105 spores (6 doses over 3 weeks) caused histopathologically detectable inflammation in
mouse lungs (Nikulin et al., 1997). The reaction was more severe with the spores of the
fungal strain capable of producing satratoxins and higher amounts of other mycotoxins.
Repeated dosing of 1 × 103 such spores induced inflammation in contrast to the spores of a
less toxic strain. In addition, it has been shown that spores of Stachybotrys chartarum
extracted with methanol to remove active secondary metabolites are markedly less potent at
provoking acute inflammation, cytotoxicity and haemorrhage in the rat lungs (Rao et al.,
2000a; 2000b). These observations indicate that toxic secondary metabolites are important in
causing inflammatory responses at least during Stachybotrys chartarum exposure.
6.4 Comparison of in vivo and in vitro responses (I - IV)
The present in vivo results are well in concordance with the data obtained in cell cultures in
vitro by the same microbial species. S. californicus and M. terrae (BA26) have been shown to
cause intense production of inflammatory mediators in mouse macrophages (Hirvonen et al.,
1997a, 1997b, 1997c; Huttunen et al., 2000). S. californicus induced significant TNFα and
IL-6 responses in these cells between 4 and 8 hours exposure (Hirvonen 1997a). Moreover,
iNOS protein was detectable from 8 hours to the end of the experiment (24 hours), and a
marked increase in nitrite concentration, an indicator of increased NO production, was
observed from 16 hours to the end of the experiment (at and above 1 × 105 spores). Severe
cytotoxicity was not observed in vitro during the exposure at the tested doses. The spores of
S. californicus induced the production of reactive oxygen species (ROS) in both human
polymorphonuclear leucocytes and mouse macrophages in vitro (Ruotsalainen et al., 1995;
Hirvonen et al., 1997c). This may partly explain the observed cytotoxicity.
M. terrae provoked immunological responses in a slower kinetics compared to S. californicus
in mouse macrophages in vitro (Huttunen et al., 2000). M. terrae induced cytokine responses
after 4 hours exposure (5 × 106 bacterial cells). Inducible NOS was detectable from 16 hours
up to 48 hours, and a marked increase in nitrite concentration, as an indicator of increased NO
production, was observed already from 8 hours to the end of the experiment. Marked
cytotoxicity was observed in vitro only after exposure to the highest tested dose of M. terrae
(5 × 107 cells/ml). These observations indicate that the same mediators are induced in vivo,
even though the time frame is somewhat different. Cytokine responses were observed slightly
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earlier in vivo, but the iNOS expression was detectable at later time points. M. terrae was not
highly cytotoxic in vitro, an observation which was corroborated in vivo. These results
suggest that alveolar macrophages are important cells in the manifestation of the in vivo
responses provoked by S. californicus and M. terrae, but are likely not the only responding
cells.
In line with the in vivo observations, S. californicus induced stronger TNFα, IL-6 and NO
responses in mouse macrophages in vitro than the fungal species A. versicolor and
P. spinulosum at the doses with equal particulate numbers (1 × 105, 1 × 106, and
1 × 107 spores) (Huttunen et al., in press). Fungi-induced IL-6 and NO production were hardly
detectable, in contrast to the very strong responses produced by the S. californicus.
A. versicolor provoked a stronger TNFα response than P. spinulosum at the doses below
1 × 107 spores in vitro. The highest dose of P. spinulosum, instead, provoked a much stronger
TNFα response compared to a similar dose of A. versicolor in vitro. A similar pattern was
evident also in vivo. The in vitro observation gives further support to the concept of
overloading, i.e. it is possible that the spores of P. spinulosum, since they are larger particles,
can cause strong production of TNFα due to a nonspecific response via overloading of the
phagocytes. P. spinulosum has been shown to be a poor inducer of the production of
inflammatory cytokines in lavaged rat alveolar macrophages in vitro (Shahan et al., 1998).
S. californicus also caused cytotoxicity in mouse macrophages in vitro at the lower dose level
than the fungal species (Huttunen et al., in press), which is corroborated by the present in vivo
findings. A marked increase in the cytotoxicity provoked by the fungal species in vitro was
detected at the highest dose (107 spores) (Huttunen et al., in press), which may partly be due
to the overloading phenomenon in those conditions. Since no IL-6 response was detected after
exposure to A. versicolor or P. spinulosum in mouse macrophages in vitro (Huttunen et al., in
press), this suggests that cells other than macrophages contribute to the response in the mouse
or perhaps the regulation of IL-6 production is more complex in vivo.
These data together indicate that mouse macrophages in vitro predict well the acute cytokine
and cytotoxic responses of these microbes in vivo. This suggests that mouse macrophages are
suitable in screening for the inflammatory and cytotoxic potential of moldy house microbes.
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6.5 Clinical implications
The observations that the indicated microbes cause inflammation in vivo suggest that they can
contribute to inflammation associated adverse health effects experienced by the occupants of
moisture-damaged buildings. An immunotoxic effect, as observed in mice after repeated
dosing of the spores of S. californicus, may interfere with the normal functions of the host
immune system and increase the risk for infections caused by other microorganisms.
However, it is not possible to make any direct quantitative extrapolations from the present
findings to exposure situations in humans in moisture-damaged buildings. It is not known
which level of exposure is sufficient to cause symptoms in humans. On the other hand, the
present studies did not reveal the lowest harmful exposure levels. Further studies are needed
to answer these questions. The species differences in sensitivity have also to be considered. In
addition, many important factors influencing the harmfulness of a specific microbe still have
to be determined. For example, the growth conditions of a microbe may affect its potency to
be harmful for the host (Nielsen et al., 1998; Nunez et al., 2000; Murtoniemi et al., 2001), as
well as the presence of other microbes growing in the same conditions (Marin et al., 1998;
Picco et al., 1999). Moreover, the occupants of moisture-damaged buildings are exposed to
several agents and microbes simultaneously, and there may be marked interactions between
different toxins or other substances. It has been shown that cell wall components, bacterial
LPS and fungal β(1,3)-D-glucan have synergistic effects to cause pulmonary inflammation
(Fogelmark et al., 1994). Mycotoxins as well as MVOC's may also have interactions, which
potentiate their toxicity (Dowd et al., 1989; Korpi et al., 1999; Carlson et al., 2001). Pollutants
in the ambient air may also have synergistic effects with moisture-damage derived hazardous
substances. However, currently very little is known about these interactions. In addition,
individual differences have a marked influence on the risk of adverse health effects caused by
exposure to microbes or their products in moisture-damaged buildings. These aspects should
also be taken into account when any risk assessment concerning the moldy building
phenomenon is being undertaken.
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7 CONCLUSIONS
The following conclusions can be drawn from the present study.
1. The studied microbes had a different potential to cause inflammatory and toxic responses
in the lungs after single dosing into the airways. Major differences were observed in their
ability to recruit inflammatory cells into the airways, and to induce IL-6 and iNOS
production. The bacterial species S. californicus and M. terrae had approximately equal
potency to evoke these responses. S. californicus provoked strong acute inflammation,
whereas M. terrae caused sustained inflammation. A. versicolor was more potent at
inducing inflammation than the other fungus, P. spinulosum. When compared based on
comparable volumetric doses, the bacterial species S. californicus and M. terrae were
more potent at inducing adverse effects than the fungal species A. versicolor and
P. spinulosum. Based on these data, P. spinulosum was the weakest inducer of
inflammation and toxicity.
2. Airway exposure to these microbes can provoke also systemic effects. Both M. terrae and
S. californicus provoked reactive changes in the lymph nodes, and S. californicus caused
immunotoxicity especially in the spleen. Moreover, exposure to the spores of
S. californicus increased the TNFα and IL-6 levels in blood.
3. Repeated dosing of S. californicus potentiated but also sometimes repressed immune
responses compared to the single dosing. Inflammatory cell recruitment into the lungs was
markedly enhanced whereas IL-6 and iNOS responses were depressed with repeated
dosing. After repeated dosing, signs of the inflammatory response in lungs were
detectable even at a very low exposure level.
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